Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
21494814	ly-cd8	% (—)	1625	3286	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Secondary uncertain malignant neoplasm

221

27.31

323.31

2.2

—

Non-Hodgkin lymphoma, all, including Hilmo

370

45.40

307.65

2.2

—

ILD medications

732

640

6.25

307.65

2.0

2.1

—

Fever of other and unknown origin

482

550

7.90

307.65

2.3

1.8

—

Primary_lymphoid and hematopoietic malignant neoplasms

563

228

25.97

307.65

2.3

1.9

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

748

790

6.60

307.65

2.2

1.9

—

Liquid cancers, helper endpoint

628

237

23.85

307.65

2.3

2.1

—

Other diseases of blood and blood-forming organs, wide

338

280

12.46

307.65

2.5

1.9

—

Non-follicular lymphoma

284

34.77

307.65

2.1

1.8

—

ILD medications: immunosuppressive drugs

578

584

9.32

307.65

2.0

2.1

—

Secondary and unspecified malignant neoplasm of lymph nodes

200

44.18

307.65

2.2

2.0

—

Agranulocytosis

240

138

18.28

296.32

2.5

1.9

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

224

111

20.85

295.30

2.2

—

Enlarged lymph nodes

248

168

15.21

280.65

2.2

1.9

—

ILD medications: prednisolone, methylprednisolone, prednisone

645

627

5.80

272.83

2.0

2.1

—

Bacterial infection, other or unspecified

434

533

7.16

272.13

2.3

1.9

—

MS-disease / Multiple Sclerosis

187

26.10

267.77

2.2

2.1

—

Demyelinating diseases of the central nervous system

197

21.60

262.24

2.2

2.0

—

Bacterial infection, other or unspecified

446

568

6.72

261.46

2.3

1.9

—

First line medication for Crohn's disease

646

631

5.57

259.05

2.1

—

Diffuse large B-cell lymphoma, helper endpoint

141

66.68

256.54

2.0

2.3

—

Diffuse large B-cell lymphoma, including Hilmo

141

66.68

256.54

2.0

2.3

—

Diffuse large B-cell lymphoma

141

66.68

256.54

2.0

2.3

—

Oral corticosteroids

660

799

4.94

245.39

1.9

2.1

—

Drug-induced neutropenia

183

20.76

238.51

2.3

1.7

—

Other bacterial diseases

595

847

4.76

224.30

2.2

2.0

—

Inflammatory bowel disease treatment related agents

657

828

4.47

213.51

1.9

2.1

—

Immunodeficiencies

133

33.21

205.94

2.5

2.0

—

Autoimmune diseases related-to ILD

519

980

4.56

204.20

2.0

—

Non-Hodgkin lymphoma, all

112

66.51

203.81

2.0

2.7

—

Immunodeficiency with predominantly antibody defects

116

52.36

200.61

2.5

1.8

—

Aplastic and other anaemias

349

528

6.24

198.72

2.2

1.9

—

Other and unspecified anaemias

324

476

6.57

195.68

2.3

1.8

—

Thrombocytopenia, unspecified

150

20.49

195.16

2.6

2.3

—

Other anaemias

324

480

6.50

193.45

2.3

1.8

—

514

635

4.93

192.98

2.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

514

635

4.93

192.98

2.0

—

Other bacterial diseases

583

874

4.26

189.02

2.2

1.9

—

L04AA Selective immunosuppressants

253

317

8.15

188.13

2.1

2.0

—

Certain disorders involving the immune mechanism

232

262

9.07

187.72

2.3

2.1

—

Pneumonias (Asthma/COPD co-morbidities)

574

933

4.16

184.59

2.0

—

Malignant neoplasm

464

533

5.19

181.56

2.2

2.1

—

Influenza and pneumonia

588

941

4.00

176.33

2.0

—

Second line medication for Crohn's disease

401

846

4.79

175.78

1.8

2.1

—

Autoimmune diseases excluding thyroid diseases

586

766

4.20

175.58

2.0

—

Purpura and other haemorrhagic conditions

189

179

10.87

174.16

2.5

2.1

—

L04AX Other immunosuppressants

392

819

4.83

173.87

1.8

2.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

574

749

4.22

173.37

2.0

—

Pneumonia, organism unspecified

515

864

4.21

170.85

2.0

—

All pneumoniae

566

964

3.95

170.20

2.0

—

Malignant neoplasm, wide definition for exclusion

451

557

4.78

161.47

2.2

2.1

—

Rare circulating lymphoid malignancy, including Hilmo

63.46

158.51

2.3

3.7

—

Pneumocystosis

64.94

153.03

2.1

1.7

—

Anaemias

202

118

11.32

150.86

2.4

2.0

—

ILD, hospital admission 2, with pulmonary infections

119

18.52

148.93

2.1

2.6

—

Coagulation defects, purpura and other haemorrhagic conditions

206

268

7.84

148.43

2.5

2.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

529

978

3.71

147.53

2.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

395

831

4.29

146.06

2.0

—

Pneumonia due to other infectious organisms, not elsewhere classified

38.57

145.41

2.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

27.01

143.30

2.2

1.9

—

Any event in cancer register

461

656

4.16

141.27

2.2

2.0

—

Protozoal diseases

39.31

140.99

2.1

1.6

—

Septicaemia

263

427

5.82

140.21

2.2

1.9

—

Follicular lymphoma, hilmo

100

24.78

140.13

2.5

1.7

—

Human immunodeficiency virus [HIV] disease

38.43

135.94

3.8

2.1

—

Unspecified human immunodeficiency virus [HIV] disease

81.13

133.68

3.4

1.5

—

Other septicaemia

236

388

5.91

129.21

2.2

1.9

—

Other demyelinating diseases of the central nervous system

28.78

128.86

2.2

2.1

—

Abnormal findings on diagnostic imaging of lung

301

619

4.71

127.74

1.9

2.0

—

Transplanted organ and tissue status

136

127

11.04

126.57

3.2

2.1

—

ILD, hospital admissions 3, with pneumonia sepsis

106

15.80

122.52

2.2

2.4

—

Lymphoid leukaemia

18.91

120.64

1.8

2.4

—

General symptoms and signs

481

669

3.62

115.54

2.3

1.8

—

Solid cancers, helper endpoint

371

525

4.19

115.07

2.0

2.1

—

Autoimmune diseases

509

768

3.39

112.18

2.0

—

Other degenerative diseases of the nervous system

213

258

6.24

110.76

2.3

1.8

—

Explicit Sepsis

268

552

4.57

109.07

2.2

1.9

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

122

14.45

108.78

2.2

1.6

—

Any reimbursement code in KELA

228

163

7.04

107.29

2.1

2.2

—

Certain infectious and parasitic diseases

408

538

3.81

105.09

2.3

1.8

—

Hodgkin lymphoma, hilmo

27.61

101.98

2.3

1.7

—

Viral infections characterized by skin and mucous membrane lesions

260

617

4.25

98.46

2.3

2.0

—

ILD medications: azathioprine

112

118

9.63

95.44

2.0

2.2

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

28.94

92.51

4.6

1.8

—

COPD/asthma related infections

425

635

3.37

92.45

2.0

—

COPD/asthma/ILD related infections

425

635

3.37

92.45

2.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

44.58

92.15

1.7

3.4

—

Chronic lymphocytic leukaemia

44.58

92.15

1.7

3.4

—

Chronic lymphocytic leukaemia, helper endpoint

44.58

92.15

1.7

3.4

—

Used for control exclusion in common control thyroid runs

452

720

3.18

90.93

2.0

—

GASTRO-related operations

317

387

4.12

90.10

2.2

1.9

—

Any gastric operation

317

387

4.12

90.10

2.2

1.9

—

Interstitial lung disease endpoints

132

186

7.22

88.75

2.1

2.0

—

Interstitial lung disease

132

186

7.22

88.75

2.1

2.0

—

ILD, hospital admissions

131

184

7.25

88.34

2.1

2.0

—

Other interstitial pulmonary diseases

132

187

7.18

88.32

2.1

2.0

—

Viral infections characterized by skin and mucous membrane lesions

406

1185

2.94

84.65

2.2

2.0

—

Infections, IBD-co-morbidities

113

10.20

83.92

2.6

1.6

—

Other respiratory diseases principally affecting the interstitium

140

227

6.26

82.37

2.1

2.0

—

Other medical care

239

539

4.02

81.58

1.6

2.3

—

Multiple myeloma, including Hilmo

32.13

81.57

2.3

2.8

—

Other and unspecified disorders of white blood cells

17.63

80.21

2.5

1.7

—

Other disorders of white blood cells

13.90

79.52

2.5

1.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

482

951

2.77

78.89

2.1

2.0

—

Failure and rejection of transplanted organs and tissues

44.88

74.99

4.6

1.5

—

Neoplasms

311

468

3.54

74.36

2.4

1.9

—

Azathioprine

112

160

7.10

74.35

2.0

2.3

—

Persons encountering health services for specific procedures and health care

466

1050

2.67

73.90

1.8

2.2

—

ILD, hospital admissions 1, main diag only

112

162

7.03

73.58

2.0

—

Oxycodone

209

469

4.06

72.60

1.9

2.0

—

Viral pneumonia

127

7.91

72.25

2.1

2.3

—

Bronchitis

455

1087

2.65

71.95

2.1

2.0

—

Use of glatiramer acetate

30.41

71.92

2.3

2.1

—

Provisional assignment of new diseases of uncertain etiology

265

793

3.36

71.71

1.9

2.0

—

Codes for special purposes

265

795

3.35

71.42

1.9

2.0

—

Covid-19 confirmed case

202

515

3.95

69.67

2.0

—

Bacterial Sepsis

228

531

3.69

68.33

2.3

1.9

—

Diagnoses used for exclusion with ILD

163

359

4.59

68.21

2.0

—

Reimbursement for rheumatic diseases

272

863

3.16

66.59

1.8

2.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

108

165

6.52

66.16

1.6

2.1

—

Systemic connective tissue disorders

195

505

3.89

65.85

2.0

2.1

—

Cytomegalovirus infection, IBD co-morbidity

23.09

65.34

2.7

1.6

—

Optic neuritis

14.71

63.23

2.2

2.0

—

Bacterial pneumonia (organism specified)

217

554

3.57

63.13

2.0

—

Acute upper respiratory infections of multiple and unspecified sites

332

868

2.85

63.07

2.2

2.0

—

Use of interferon beta-1a

23.04

62.65

2.2

2.1

—

L04AD Calcineurin inhibitors

104

166

6.39

62.31

2.6

2.0

—

Other/unspecified cytomegaloviral diseases

26.88

61.89

2.8

1.6

—

Cytomegaloviral disease

19.48

60.80

2.7

1.5

—

Zoster [herpes zoster]

123

236

5.28

60.65

2.1

2.0

—

Fungal Sepsis

18.03

60.35

2.0

1.7

—

Implicit fungal Sepsis

18.35

59.57

2.1

1.7

—

Persons encountering health services in other circumstances, wide

456

952

2.47

59.54

2.1

2.0

—

Zoster [herpes zoster]

223

663

3.33

59.50

2.2

1.9

—

Viral Sepsis

128

260

4.98

59.12

2.1

2.0

—

Other and unspecified immunodeficiencies with predominantly antibody defects

140.42

58.42

3.0

1.8

—

Implicit viral Sepsis

127

259

4.96

58.39

2.1

2.0

—

All influenza

129

270

4.81

57.45

2.2

2.1

—

Implicit bacterial Sepsis

193

473

3.64

57.35

2.3

1.9

—

Herpesviral [herpes simplex] infections

152

6.35

56.76

2.5

2.1

—

COPD differential diagnosis

280

442

3.18

56.47

2.1

2.0

—

ILD differential diagnosis

280

442

3.18

56.46

2.1

2.0

—

Dental caries

140

308

4.40

55.21

2.3

1.8

—

Other pulmonary diagnosis

279

447

3.14

55.02

2.1

2.0

—

Excluding asthma or asthma-COPD overlap

278

447

3.13

54.52

2.1

2.0

—

Implicit bacterial Sepsis

202

512

3.43

54.50

2.3

1.9

—

Renal failure

212

573

3.29

54.02

2.2

1.9

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

391

1042

2.45

53.77

2.3

2.0

—

All chronic kidney diseases

240

641

3.08

53.70

2.1

2.0

—

Multiple myeloma and malignant plasma cell neoplasms

12.07

53.37

2.3

1.8

—

423

904

2.42

53.16

2.1

2.0

—

Mantle cell lymphoma, including Hilmo

93.37

53.15

2.4

1.6

—

Implicit viral Sepsis

149

372

4.04

53.01

2.2

1.9

—

Asthma, unspecified (mode), excluding more controls

189

396

3.59

52.37

2.2

2.0

—

Asthma, unspecified (mode)

190

405

3.55

51.94

2.2

2.0

—

Polyarthropathies

301

729

2.71

50.51

1.8

2.1

—

All kidney diseases

389

1129

2.36

50.10

2.1

2.0

—

Caries of dentine

126

280

4.41

50.04

2.2

1.8

—

Asthma

254

438

3.05

48.82

2.1

2.0

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

16.75

48.81

2.0

3.3

—

Renal tubulo-interstitial diseases

344

1062

2.42

47.75

2.1

2.0

—

Chronic kidney disease

147

383

3.79

47.75

2.1

1.8

—

Asthma, excluding more controls

248

425

3.05

47.66

2.1

2.0

—

Other diseases of pleura

203

576

3.11

47.08

1.9

—

Sarcoidosis

185

5.20

46.19

2.1

—

Implicit fungal Sepsis

9.20

46.07

2.0

2.1

—

Malignant neoplasm of brain, including Hilmo

13.70

46.01

1.8

1.7

—

Other symptoms and signs involving the nervous and musculoskeletal systems

194

634

3.08

45.74

2.4

2.0

—

Malignant neoplasm of brain

18.08

45.60

1.6

1.7

—

Certain infectious and parasitic diseases

242

401

3.03

45.36

2.3

1.7

—

Asthma (only as main-diagnosis)

229

438

3.04

45.28

2.1

2.0

—

Malignant neoplasm of eye, brain and central nervous system

15.14

45.18

1.7

—

Marginal zone B-cell lymphoma, including Hilmo

69.72

44.97

2.6

1.4

—

Asthma (only as main-diagnosis), excluding more controls

226

425

3.05

44.86

2.1

2.0

—

Disorders of optic nerve and visual pathways

117

6.42

44.79

2.4

1.9

—

Acute sinusitis

215

696

2.87

44.15

1.9

2.0

—

Osteoporosis

130

312

3.92

43.75

1.9

2.1

—

Asthma (mode)

241

442

2.93

43.74

2.2

2.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

240

912

2.64

42.75

2.3

2.0

—

Methotrexate

140

5.70

42.55

1.9

2.2

—

Osteopathies and chondropathies

231

800

2.70

42.35

1.9

2.1

—

Myeloid leukaemia

16.20

41.90

4.1

1.5

—

Implicit Sepsis

279

851

2.48

41.06

2.2

2.0

—

Other acute lower respiratory infections

220

778

2.71

40.70

2.1

2.0

—

Acute upper respiratory infections

371

1044

2.19

39.47

2.1

1.9

—

Other systemic involvement of connective tissue (FG)

121

322

3.73

38.64

2.1

—

Headache

206

598

2.76

38.04

2.2

1.8

—

Disorders of other endocrine glands

187

661

2.80

37.13

2.1

2.0

—

Other reaction to severe stress, and adjustment disorders

168

575

2.94

36.65

2.2

2.0

—

Venous thromboembolism

207

761

2.64

36.61

1.9

2.0

—

Streptococcal septicaemia

7.35

36.44

2.1

2.3

—

SLE (Finngen)

14.06

35.73

2.1

2.8

—

Malaise and fatigue

161

426

3.05

35.67

2.2

1.8

—

Malignant neoplasm of respiratory system and intrathoracic organs

108

5.58

35.57

1.7

2.0

—

Adrenocortical insufficiency

12.35

35.11

1.8

1.6

—

Neurological diseases, wide definition

105

112

4.72

35.11

2.5

1.7

—

Herpesviral [herpes simplex] infections

120

345

3.50

35.01

2.3

2.1

—

Viral pneumonia (unknown virus, not influenza)

6.73

34.85

2.1

2.2

—

Neurological diseases

307

671

2.30

34.60

2.3

2.0

—

Acute bronchitis

170

592

2.83

34.51

2.0

2.1

—

Mycoses

130

400

3.27

34.10

2.2

2.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

109

124

4.42

33.96

2.2

1.6

—

Asthma-related pneumonia

156

535

2.93

33.82

2.0

—

Asthma-related pneumonia or sepsis

156

536

2.92

33.70

2.0

—

Asthma, hospital admissions 3, pneumonia

156

536

2.92

33.70

2.0

—

Seropositive rheumatoid arthritis

114

324

3.53

33.63

1.6

2.0

—

Implicit Sepsis

283

926

2.24

33.09

2.1

2.0

—

Bacterial pneumoniae

140

400

3.10

32.61

2.0

—

Other viral diseases

135

438

3.09

32.23

2.5

2.1

—

Presence of other functional implants

214

589

2.53

32.23

1.9

2.0

—

Systemic lupus erythematosus

11.63

31.88

2.1

2.2

—

Other disorders of adrenal gland

9.45

31.87

1.9

—

Asthma-related infections

224

930

2.37

31.66

2.0

—

Asthma, hospital admission 2, infections

224

930

2.37

31.66

2.0

—

Other heart diseases

186

450

2.71

31.50

2.2

—

Rheumatoid arthritis

141

422

3.01

31.43

1.7

2.0

—

Other systemic involvement of connective tissue

126

400

3.17

31.43

2.1

2.0

—

Finngen Rheumatological endpoints

334

907

2.10

31.35

2.0

2.1

—

Explicit bacterial Sepsis

110

5.51

31.24

2.1

2.0

—

Other abnormal findings of blood chemistry

8.09

31.19

2.6

1.8

—

Cardiovascular diseases (excluding rheumatic etc)

237

563

2.43

31.19

2.1

—

Dermatitis due to substances taken internally

7.67

30.61

2.0

1.9

—

Oedema, not elsewhere classified

106

303

3.47

30.48

1.9

—

Complications of surgical and medical care, not elsewhere classified

346

1180

2.01

30.43

2.2

2.0

—

Rheumatoid arthritis, including avohilmo

157

575

2.74

30.31

1.7

2.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

111

5.08

30.08

1.6

2.1

—

Bronchiectasis

5.89

30.08

1.8

2.1

—

Other and unspecified dermatitis

201

833

2.42

30.07

2.3

2.0

—

Acute renal failure

279

3.57

29.85

2.3

1.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

286

951

2.13

29.34

2.2

2.0

—

Asymptomatic human immunodeficiency virus [HIV] infection status

64.53

29.09

2.3

1.7

—

Nausea and vomiting

111

335

3.26

28.96

2.1

2.0

—

Dermatitis

224

986

2.27

28.94

2.4

1.9

—

Care involving dialysis

6.10

28.90

1.8

2.7

—

Other necrotizing vasculopathies (FG)

6.82

28.90

2.4

2.0

—

Nephropathy related operations

162

4.43

28.70

2.0

2.1

—

Other viral diseases

157

588

2.66

28.56

2.4

2.1

—

Complications of medical and surgical care

260

1121

2.14

28.55

2.3

2.0

—

Persons with potential health hazards related to communicable diseases

158

594

2.65

28.45

2.1

2.0

—

SLE, strict definition

10.22

28.35

2.1

—

SLE, ICD10

10.22

28.35

2.1

—

Abnormal findings on diagnostic imaging of central nervous system

9.33

28.31

2.3

1.9

—

Diseases of the respiratory system

195

377

2.60

28.21

2.0

1.9

—

Gout, FINNGEN

114

367

3.11

27.68

1.8

—

Lung cancer and mesothelioma

138

4.43

27.46

1.6

2.2

—

Acute generalized exanthematous pustulosis

8.33

27.42

2.0

1.8

—

Other infectious diseases

102

5.35

27.27

1.9

2.2

—

Heart failure, not strict

263

839

2.14

27.01

1.9

2.1

—

Respiratory conditions due to other external agents

28.99

26.90

1.7

—

DVT of lower extremities and pulmonary embolism

155

597

2.60

26.89

1.9

—

Glomerular diseases

270

3.47

26.87

2.0

2.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

294

997

2.04

26.86

2.1

2.0

—

Pleural effusion

184

4.05

26.73

1.9

2.0

—

Other bacterial intestinal infections

238

3.64

26.70

2.5

2.0

—

Symptoms and signs involving the skin and subcutaneous tissue

247

1148

2.11

26.60

2.3

1.9

—

Dialysis, with operation codes

164

4.25

26.48

1.9

2.1

—

Pulmonary heart disease, diseases of pulmonary circulation

129

460

2.82

26.26

1.9

2.0

—

Seropositive rheumatoid arthritis, wide

114

380

3.02

26.25

1.6

2.1

—

Secondary hypertension

6.27

26.07

1.9

2.2

—

Gout

114

330

3.06

26.02

1.8

2.0

—

Sulfasalazine

305

3.26

26.01

1.7

2.3

—

Medical observation and evaluation for suspected diseases and conditions

228

508

2.30

25.93

2.0

1.9

—

General examination and investigation of persons without complaint and reported diagnosis

224

508

2.31

25.79

2.4

1.9

—

Enterocolitis due to Clostridium difficile

131

4.63

25.64

2.6

2.1

—

Other/unspecified seropositive rheumatoid arthritis

112

375

3.00

25.60

1.6

2.0

—

Non-small cell lung cancer, including Hilmo

5.59

25.51

1.5

2.1

—

170

699

2.42

25.48

1.9

2.1

—

Opioids

318

833

1.99

25.34

2.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

111

372

3.00

25.34

1.6

2.0

—

Intestinal infectious diseases

319

1264

1.92

25.17

2.3

2.0

—

Pulmonary heart disease

120

423

2.85

24.99

1.9

—

Pulmonary embolism

120

423

2.85

24.99

1.9

—

Dermatitis and eczema

368

1236

1.85

24.86

2.2

2.0

—

Chorioretinal inflammation

9.31

24.81

2.0

1.8

—

Idiopathic pulmonary fibrosis

5.94

24.79

1.7

2.2

—

Other necrotizing vasculopathies

5.54

24.61

2.4

1.9

—

Acute myeloid leukaemia and myelodysplastic syndromes

50.07

24.43

4.1

1.3

—

Lung diseases due to external agents

166

4.07

24.35

2.0

2.1

—

Generalized skin eruption due to drugs and medicaments

8.01

24.33

2.0

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

114

254

3.05

24.26

1.8

2.1

—

Disorders of mineral metabolism

102

5.06

24.20

2.3

1.9

—

Systemic lupus erythematosus, unspecified

9.87

24.18

2.0

2.1

—

Myelodysplastic syndrome, including Hilmo

29.88

24.17

2.5

3.9

—

Diseases of the skin and subcutaneous tissue

320

823

1.95

24.16

2.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

134

4.45

24.05

3.7

2.1

—

Other disorders of fluid, electrolyte and acid-base balance

119

404

2.82

24.03

2.0

1.9

—

Malignant neoplasm of skin

116

266

3.00

24.01

1.7

2.1

—

Other infectious diseases

5.40

24.00

1.8

2.3

—

Cough

151

577

2.49

23.75

1.9

2.1

—

Malignant immunoproliferative diseases

36.24

23.75

1.5

1.7

—

Dyspnoea

298

1145

1.93

23.73

1.7

2.1

—

Bacterial intestinal infections, IBD co-morbidities

254

3.37

23.52

2.5

2.1

—

Abnormalities of breathing

298

889

1.95

23.31

1.7

2.1

—

Osteonecrosis

5.84

23.22

1.8

1.9

—

Other disorders of lacrimal gland

138

544

2.55

23.15

2.2

2.1

—

Mixed connective tissue disease

5.44

23.08

2.2

1.9

—

Osteoporosis with pathological fracture (FG)

5.93

23.07

1.9

1.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

105

233

3.10

22.99

1.6

2.1

—

Use of teriflunomide

34.56

22.73

2.3

1.8

—

Nutritional anaemias

167

699

2.31

22.47

2.4

2.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

6.05

22.46

1.9

2.3

—

Other heart diseases, wide

306

987

1.90

22.44

2.1

—

Malignant neoplasm of bronchus and lung

4.80

22.39

1.6

2.1

—

Other arthritis (FG)

116

427

2.73

22.33

2.1

2.0

—

Haemolytic anaemias

9.16

22.13

1.9

1.8

—

Tramadol

251

763

2.03

22.10

2.1

2.0

—

Malignant neoplasm of digestive organs

220

3.24

22.08

1.8

2.1

—

Erysipelas

158

597

2.35

21.72

1.7

1.9

—

Metabolic disorders

309

1009

1.87

21.70

2.1

—

Disorders of lacrimal system

156

670

2.33

21.59

2.2

2.0

—

Hypertensive diseases (excluding secondary)

177

443

2.33

21.55

1.9

2.2

—

Malignant neoplasm of urinary organs

6.11

21.54

1.8

2.4

—

Iron deficiency anaemia

146

603

2.39

21.42

2.4

2.0

—

Any death

214

734

2.09

21.33

1.5

2.1

—

Candidiasis

188

3.65

21.24

2.1

2.0

—

Glomerulonephritis

139

4.14

21.23

2.1

—

All influenza (not pneumonia)

152

3.97

21.19

1.9

2.4

—

Parasetamol

233

566

2.09

21.19

2.2

2.0

—

Inflammatory diseases of the central nervous system

111

4.55

21.00

2.1

2.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

5.05

20.91

2.1

2.0

—

Use of fingolimod

32.36

20.88

1.9

2.8

—

Other bacterial intestinal infections

332

2.91

20.81

2.6

2.0

—

Noninfective enteritis and colitis

167

752

2.23

20.75

2.1

—

Cardiovascular diseases

204

507

2.17

20.66

2.1

2.2

—

Bacterial pneumonia, not elsewhere classified

113

372

2.68

20.54

1.9

2.0

—

Viral pneumonia (known virus, not influenza)

18.78

20.50

2.2

2.6

—

Abnormal findings on examination of blood, without diagnosis

171

714

2.21

20.48

2.4

1.9

—

Undetermined asthma

109

4.52

20.48

2.1

2.3

—

Basal cell carcinoma, including avohilmo

100

233

2.96

20.44

1.6

2.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

213

508

2.13

20.27

2.3

1.9

—

L01XX Other antineoplastic agents

5.89

20.11

1.8

1.9

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

132

4.11

20.03

1.5

2.1

—

Biological medication for rheuma

260

3.14

20.03

1.7

2.1

—

Symptoms and signs involving the digestive system and abdomen

315

860

1.84

19.99

2.2

2.0

—

Depression medications

126

3.44

19.85

2.1

1.9

—

Malignant neoplasm of kidney, except renal pelvis

6.12

19.83

1.9

2.4

—

Other specified/unspecified arthritis

104

388

2.69

19.57

2.0

—

Kidney transplant status

5.71

19.47

2.1

2.0

—

Disorders of calcium metabolism

5.26

19.38

2.4

1.9

—

Codeine

283

824

1.87

19.32

2.1

2.0

—

Other specified/unspecified systemic involvement of connective tissue

5.51

19.32

2.2

2.0

—

Other noninfective gastroenteritis and colitis

353

2.76

19.13

2.1

—

Other pleural conditions

100

4.54

18.89

1.8

2.0

—

Persons encountering health services in other circumstances

127

528

2.40

18.86

2.0

—

Extracorporeal dialysis

5.13

18.84

1.9

2.4

—

Undetermined asthma, excluding more controls

117

4.21

18.75

2.1

2.2

—

Pneumonia due to Streptococcus pneumoniae

7.39

18.68

2.4

2.3

—

Basal cell carcinoma

221

2.92

18.59

1.6

2.0

—

163

3.64

18.49

1.9

2.3

—

Chronic sinusitis

153

700

2.19

18.37

1.9

2.0

—

Exclusions for E4_PCOS_BROAD

254

3.05

18.19

2.3

2.1

—

L01XE Protein kinase inhibitors

5.29

17.99

1.7

—

Idiopathic thrombocytopenic purpura

13.97

17.82

2.0

1.6

—

Hypercalcemia

6.22

17.69

2.7

2.1

—

Diseases of the eye and adnexa

253

671

1.89

17.59

2.2

2.0

—

Malignant neoplasm of head and neck

6.35

17.53

1.8

2.6

—

Other diseases of pericardium

6.60

17.49

2.3

2.1

—

Erysipelas

187

707

2.02

17.39

1.7

2.0

—

Candidiasis

108

436

2.49

17.37

2.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

223

1074

1.87

17.13

2.3

2.0

—

Common variable immunodeficiency

38.31

16.99

1.9

1.5

—

Drug-induced osteoporosis with pathological fracture

22.70

16.98

1.8

1.3

—

Abdominal and pelvic pain

302

860

1.77

16.98

2.2

2.0

—

Disorders of lens

215

694

1.94

16.97

1.9

2.0

—

Hypothyroidism (congenital or acquired)

121

3.37

16.94

2.0

—

Covid-19 suspected case

321

2.72

16.81

1.7

2.2

—

Infections of the skin and subcutaneous tissue

196

1008

1.93

16.75

2.0

2.1

—

Other disorders of skin and subcutaneous tissue

214

1011

1.88

16.71

1.9

2.0

—

Tumor necrosis factor alpha inhibitors

241

3.01

16.65

1.6

2.1

—

Visual disturbances

159

770

2.07

16.59

1.9

2.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

28.07

16.54

2.9

1.6

—

Multiple myeloma

28.07

16.54

2.9

1.6

—

Visual disturbances and blindness

168

832

2.02

16.47

1.9

2.0

—

Other/unspecified rheumatoid arthritis

162

3.48

16.43

1.8

2.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

121

3.92

16.34

2.1

—

Postprocedural disorders of nervous system

100

4.24

16.21

1.9

—

Infection due to other mycobacteria

31.00

16.20

2.7

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

141

399

2.24

16.20

2.1

2.2

—

Respiratory disorders in diseases classified elsewhere

25.47

16.13

2.3

1.7

—

Sicca syndrome [Sjögren]

109

4.08

16.12

1.9

—

Chronic lower respiratory diseases

368

1199

1.64

15.98

2.0

—

Drug-induced adrenocortical insufficiency

14.98

15.95

1.5

1.6

—

Disorders resulting from impaired renal tubular function

6.45

15.86

2.3

1.5

—

Malignant neoplasm of mesothelium and soft tissue

14.67

15.85

2.2

2.7

—

Gastrointestinal diseases

176

426

2.07

15.81

2.1

2.0

—

Diseases of oesophagus, stomach and duodenum

322

1149

1.68

15.80

1.9

2.1

—

Chronic apical periodontitis

341

1174

1.66

15.76

2.1

2.0

—

Syncope and collapse

111

401

2.38

15.73

2.2

1.9

—

Gastro-oesophageal reflux disease

216

1013

1.84

15.70

1.7

2.1

—

Other and unspecified drugs and medicaments

116

3.92

15.63

2.2

2.0

—

Other endocrine disorders

5.73

15.58

2.3

1.8

—

Hypothyroidism, strict autoimmune

180

597

1.99

15.48

1.9

2.0

—

Other respiratory disorders and diseases

285

2.75

15.40

1.7

2.1

—

Other diseases of the respiratory system

285

2.75

15.40

1.7

2.1

—

Hernia of abdominal wall, postoperative

122

3.78

15.33

2.3

1.8

—

Secondary thrombocytopenia

24.38

15.24

2.7

1.9

—

Valvular heart disease excluding rheumatic fever

149

513

2.10

15.23

2.1

2.0

—

Other symptoms and signs involving the digestive system and abdomen

206

3.07

15.19

2.1

—

Neurotic, stress-related and somatoform disorders

276

1128

1.71

15.15

2.1

2.0

—

Non-small cell lung cancer

5.46

15.06

1.4

2.3

—

Hypertensive diseases

242

760

1.80

14.99

2.0

2.2

—

Hypertension

242

760

1.80

14.98

2.0

2.1

—

Hypothyroidism and >3 levothyroxin purchases

121

3.19

14.77

1.9

2.0

—

Hypothyroidism, levothyroxine purchases

121

3.19

14.77

1.9

2.0

—

Dental operations

181

468

1.99

14.74

2.3

2.0

—

Malignant neoplasm of other connective and soft tissue

21.45

14.70

2.0

1.3

—

Acute tubulo-interstitial nephritis

182

826

1.91

14.68

2.1

2.0

—

Noninfectious colitis NAS

185

3.15

14.61

2.1

—

Disorders of eyelid, lacrimal system and orbit

258

1142

1.72

14.52

2.2

2.0

—

Anxiety disorders

276

1140

1.69

14.39

2.1

2.0

—

Asthma (diagnoses ohter than nonallergic)

263

1288

1.70

14.36

2.1

2.0

—

Intestinal infectious diseases

342

1212

1.61

14.35

2.3

1.9

—

Symptoms and signs involving the urinary system

235

1020

1.76

14.35

2.0

—

Glomerular disorders in diseases classified elsewhere

162

3.30

14.32

2.0

2.2

—

Abnormal findings on diagnostic imaging of other body structures

167

3.25

14.31

2.4

2.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

184

975

1.87

14.29

2.5

1.9

—

Etanercept

4.42

14.26

1.4

2.2

—

Other (seronegative) rheumatoid arthritis, wide

280

2.69

14.25

1.7

2.0

—

Cellulitis

321

2.57

14.16

1.9

2.1

—

Other disorders of urethra and urinary system

210

836

1.82

14.15

2.0

—

Unspecified kidney failure

102

3.95

14.12

2.4

2.0

—

Heart failure,strict

161

575

1.98

14.00

1.8

2.1

—

Senile cataract

189

614

1.89

13.91

2.0

1.9

—

Other complications of surgical and medical care, not elsewhere classified

136

3.48

13.85

2.0

2.2

—

Hypertension, essential

233

745

1.77

13.79

1.9

2.1

—

Non-rheumatic valve diseases

144

512

2.03

13.56

2.1

2.0

—

Other acute disseminated demyelination

26.86

13.48

2.7

3.1

—

Acquired haemolytic anaemia

13.08

13.45

1.5

1.4

—

Other and unspecified iron deficiency

108

490

2.21

13.40

2.7

2.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

11.58

13.30

2.1

2.5

—

Pneumonia derived septicemia

9.79

13.24

2.0

2.3

—

Diseases of the digestive system

137

682

2.00

13.18

1.8

2.0

—

Invasive ventilation

4.23

13.16

1.9

2.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

5.10

13.08

1.9

2.2

—

Hypo-osmolality and hyponatraemia

229

2.79

13.06

2.4

2.0

—

Conjunctivitis (acute, non atopic)

438

2.26

12.98

2.0

2.1

—

Bleeding

244

1026

1.69

12.96

1.9

2.1

—

Morphin

19.42

12.95

1.5

1.3

—

Hypoparathyroidism

6.20

12.95

1.4

1.5

—

Other overlap syndromes

23.07

12.95

2.1

2.9

—

Factors influencing health status and contact with health services

148

2.72

12.90

2.0

2.1

—

Care involving use of rehabilitation procedures

174

870

1.84

12.88

2.0

2.2

—

Donors of organs and tissues

14.48

12.84

2.6

1.8

—

Diseases of oral cavity, salivary glands and jaws

171

457

1.93

12.83

2.2

1.8

—

Pain, not elsewhere classified

290

2.56

12.78

1.8

1.9

—

Other functional intestinal disorders

138

647

1.98

12.77

2.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

247

2.42

12.76

1.8

1.9

—

Malignant neoplasm of breast, including Hilmo

247

2.42

12.76

1.8

1.9

—

Use of dimethyl fumarate

33.52

12.69

2.2

3.6

—

Malignant neoplasm of breast, HER2-negative

239

2.44

12.65

1.7

1.9

—

Malignant neoplasm of breast, ER-negative, including Hilmo

143

3.21

12.38

1.9

—

Chronic nephritic syndrome

5.86

12.28

2.0

1.9

—

Pneumococcal septicemia

9.08

12.26

2.0

—

Clear cell adenocarcinoma of kidney

10.58

12.26

2.0

2.4

—

Heart failure and antihypertensive medication

251

2.38

12.25

1.9

2.1

—

Low back pain

231

983

1.69

12.22

2.2

2.0

—

Other diseases of intestines

313

1127

1.58

12.18

2.0

—

Malignant neoplasm of breast

243

2.39

12.15

1.8

1.9

—

Asthma, hospital admissions , main diagnosis only

238

1268

1.66

12.15

2.0

—

5-aminosalicylic acid

234

2.70

12.14

1.6

2.4

—

Atrial fibrillation and flutter

274

2.30

12.12

2.0

2.2

—

Anxiety disorders, excluding more controls

255

1008

1.65

12.05

2.2

1.9

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

5.71

11.97

2.2

2.1

—

Papulosquamous disorders

124

623

2.00

11.86

1.9

2.1

—

Other meningitis

15.02

11.85

1.8

—

Malignant neoplasm of bladder, including Hilmo

4.80

11.77

1.5

2.4

—

Contact with and exposure to communicable diseases

104

489

2.12

11.75

1.8

2.1

—

Malignant neoplasm, without specification of site, including Hilmo

10.57

11.75

2.0

3.7

—

Codeine or tramadol medication

329

1161

1.55

11.74

2.1

2.0

—

Cerebrovascular diseases (FINNGEN)

293

2.28

11.72

2.2

—

Symptoms and signs involving the circulatory and respiratory systems

286

893

1.61

11.57

2.1

—

Other disorders involving the immune mechanism, not elsewhere classified

8.72

11.54

2.5

2.1

—

Other diseases of urinary system

295

1049

1.58

11.52

2.2

2.0

—

Malignant neoplasm of breast, HER-negative

125

3.31

11.48

1.8

1.9

—

Iron deficiency anaemia secondary to blood loss (chronic)

213

2.74

11.46

1.5

2.1

—

Other autoimmune haemolytic anaemias

15.57

11.40

1.5

1.4

—

Carrier of infectious disease

9.76

11.28

2.4

2.1

—

Myasthenia gravis

17.44

11.24

1.8

—

Asthma and opportunity respiratory infection

4.95

11.22

2.2

1.8

—

Drug-induced osteoporosis

25.77

11.20

1.5

2.2

—

Psoriasis

442

2.16

11.19

1.9

2.1

—

Chronic iridocyclitis

4.76

11.19

1.5

2.2

—

Complications following infusion, transfusion and therapeutic injection

25.61

11.19

3.1

1.7

—

Postzoster neuralgia

20.52

11.18

2.4

1.6

—

Diseases of pulp and periapical tissues and dental caries

192

556

1.77

11.18

2.1

1.9

—

Antihypertensive medication - note that there are other indications

190

570

1.77

11.12

2.1

—

Mycoses

249

1355

1.60

11.06

2.0

—

Heart failure, strict

165

645

1.81

11.03

1.7

2.0

—

Disorders of parathyroid gland

266

2.50

11.03

1.8

2.0

—

Viral warts

288

2.44

10.99

2.0

2.1

—

Disorders of sclera, cornea, iris and ciliary body

164

926

1.78

10.97

2.0

2.1

—

Hyperkalaemia

4.67

10.94

1.7

—

Adalimumab

138

3.14

10.82

1.9

2.1

—

Atypical mycobacterium lung infection

22.13

10.75

2.7

1.4

—

Hypopituitarism

3.79

10.74

2.1

—

All-cause Heart Failure

162

636

1.80

10.73

1.7

2.0

—

Non-ischemic cardiomyopathy

357

2.15

10.66

1.9

2.0

—

Ischemic heart diseases

235

865

1.63

10.64

1.7

2.1

—

Encephalitis

8.07

10.62

2.5

1.7

—

Skin changes due to chronic exposure to nonionizing radiation

105

476

2.04

10.57

1.5

2.0

—

Actinic keratosis

103

466

2.05

10.55

1.5

2.0

—

Viral infections of the central nervous system

3.65

10.51

3.1

1.9

—

Defects in the complement system

+∞

10.48

2.1

0.0

—

Symptoms and signs concerning food and fluid intake

3.55

10.42

3.7

1.8

—

Respiratory insufficiency

4.63

10.42

1.5

2.8

—

Other encephalitis

7.81

10.41

2.5

1.7

—

Wegener granulomatosis

16.41

10.40

1.7

2.0

—

Exposure to unspecified factor

285

1335

1.54

10.37

2.0

—

Polyarthrosis

245

2.47

10.37

1.7

1.9

—

Persons encountering health services for examination and investigation

179

508

1.77

10.36

2.3

1.9

—

Malignant neoplasm of colon, including Hilmo

116

3.28

10.35

2.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

19.47

10.34

2.8

1.9

—

Aspergillosis

24.35

10.33

3.1

1.7

—

Leukaemia of unspecified cell type

24.24

10.32

3.8

1.7

—

Other skin changes

273

2.43

10.28

2.4

2.0

—

Dental caries, including avohilmo

211

643

1.68

10.28

2.0

1.9

—

Hyperlipidaemia, other/unspecified

113

531

1.96

10.26

1.7

2.0

—

Diseases of pulp and periapical tissues, including avohilmo

299

1007

1.54

10.25

2.0

—

Other abnormalities of plasma proteins

13.43

10.21

2.0

1.5

—

Psoriasis vulgaris

269

2.43

10.12

2.0

2.1

—

Viral hepatitis, IBD co-morbidity

5.29

10.11

4.7

1.8

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

8.54

10.07

2.6

2.1

—

Endocrine disorders, other/unspecified

14.83

10.03

2.1

1.6

—

Caries of dentine, including avohilmo

222

690

1.65

10.01

2.0

—

Viral warts

129

3.12

10.01

2.3

2.1

—

Volume depletion

3.45

10.00

2.1

1.9

—

Diseases of the musculoskeletal system and connective tissue

151

412

1.84

9.94

2.4

2.1

—

Seropositive rheumatoid arthritis, strict definition

212

2.61

9.94

1.7

2.1

—

Brain glioblastoma and astrocytoma

17.03

9.91

1.2

1.8

—

FESS (DNB20)

196

2.67

9.83

1.8

2.1

—

Other disorders of bladder

169

2.80

9.72

1.6

2.1

—

Disorders of thyroid, IBD co-morbidities

3.24

9.71

2.0

1.6

—

Endocrine, nutritional and metabolic diseases

228

713

1.62

9.69

2.3

2.0

—

Asthma, including avohilmo

333

1265

1.48

9.69

2.0

—

Simple and mucopurulent chronic bronchitis

5.32

9.64

1.6

2.3

—

Diseases of middle ear and mastoid

172

830

1.70

9.60

1.8

2.1

—

108

511

1.94

9.53

1.6

2.0

—

Haemorrhage from respiratory passages

423

2.03

9.46

1.9

2.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

200

2.61

9.46

1.5

2.2

—

Seborrhoeic dermatitis

118

3.15

9.45

2.5

2.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.80

9.42

2.0

—

Non-allergic asthma (mode), excluding more controls

159

2.81

9.42

1.8

2.2

—

Ethmoidectomy

207

2.58

9.36

1.8

2.1

—

Diseases of the ear and mastoid process

328

1114

1.48

9.33

2.0

—

Dialysis

4.93

9.32

2.4

1.6

—

Acute lymphadenitis

3.97

9.32

3.3

1.9

—

Type 2 diabetes, wide definition

228

924

1.58

9.24

2.0

—

Intracranial trauma

144

570

1.78

9.23

1.9

2.0

—

Non-allergic asthma (mode)

161

2.78

9.21

1.8

2.2

—

Inflammatory bowel disease

100

512

1.96

9.19

1.9

2.1

—

Dysphagia

313

2.24

9.17

2.4

1.9

—

Acute bronchiolitis

4.27

9.16

3.2

2.1

—

Viral infections of the central nervous system

100

3.32

9.16

3.1

1.9

—

Anaemia in chronic diseases classified elsewhere

11.61

9.09

1.4

1.6

—

Mature T/NK-cell lymphomas, hilmo

15.96

9.08

1.9

1.3

—

Malignant neoplasm of tonsil

15.93

9.07

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

276

1209

1.51

9.07

2.3

1.9

—

Malignant neoplasm of oropharynx

15.89

9.07

1.4

—

Malignant neoplasm of small intestine

15.80

9.05

2.5

1.3

—

Hypokalaemia

148

2.85

9.04

1.6

2.0

—

Disorders of gallbladder, biliary tract and pancreas

272

1136

1.51

9.00

2.0

—

Constipation

245

1103

1.54

8.97

2.0

—

Brain glioblastoma

19.02

8.97

1.2

1.6

—

Other cataract

119

486

1.86

8.90

2.2

1.9

—

Convulsions, not elsewhere classified

239

2.40

8.88

2.7

2.0

—

Complications of procedures, not elsewhere classified

217

1148

1.57

8.85

1.8

2.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

263

1113

1.51

8.84

2.0

—

Hard cardiovascular diseases

233

892

1.56

8.80

1.9

2.1

—

Cardiac arrhythmias

166

639

1.69

8.79

1.9

2.2

—

Other viral diseases, not elsewhere classified

389

2.08

8.76

2.2

2.1

—

6-mercaptopurine

7.23

8.74

1.6

2.2

—

Other soft tissue disorders, not elsewhere classified

263

1018

1.52

8.72

2.1

2.0

—

Diseases of spleen

14.27

8.72

2.5

1.3

—

Crohn's disease NAS

3.67

8.72

1.4

2.1

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

14.25

8.72

1.9

3.9

—

Episodal and paroxysmal disorders

309

1068

1.47

8.69

2.0

2.1

—

Any operation in hilmo

+∞

8.66

1.9

0.0

—

Nonsuppurative otitis media

297

2.16

8.66

2.1

—

Diseases of liver

105

559

1.88

8.62

2.1

2.0

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

16.84

8.62

2.2

1.5

—

Pain in throat and chest

224

862

1.56

8.56

2.2

2.1

—

Rash and other nonspecific skin eruption

131

2.92

8.53

2.2

2.0

—

Other specified/unspecified necrotizing vasculopathies

20.43

8.50

2.7

1.7

—

ILD-related respiratory insufficiency

7.41

8.46

1.8

1.7

—

Unspecified acute lower respiratory infection

194

2.54

8.45

2.5

2.3

—

Malignant neoplasm of tonsil, including Hilmo

12.99

8.40

1.4

1.6

—

Use of hypnotics and sedatives

295

1156

1.47

8.33

2.3

2.0

—

Malignant neoplasm of colon

3.38

8.33

2.0

2.2

—

Systemic sclerosis

8.64

8.33

2.4

2.0

—

Percutaneous Coronary Intervention

214

839

1.57

8.30

1.7

2.1

—

Sequelae with surgical and medical care as external cause

314

2.17

8.29

2.7

2.0

—

Seronegative rheumatoid arthritis

150

2.75

8.26

1.6

2.1

—

Dorsalgia

280

1012

1.48

8.26

2.3

2.0

—

Chronic myeloproliferative disease

14.80

8.24

3.1

1.4

—

Acute suppurative otitis media

399

1.99

8.17

1.9

2.1

—

Urticaria and erythema

108

591

1.83

8.15

2.0

2.2

—

Viral meningitis

4.57

8.13

2.3

1.8

—

Malignant cancer of tonsil and base of tongue

11.87

8.10

1.4

1.5

—

Acute lymphocytic leukaemia, helper endpoint

22.89

8.08

2.6

3.4

—

Acute lymphocytic leukaemia

22.89

8.08

2.6

3.4

—

Acute lymphocytic leukaemia, including Hilmo

22.89

8.08

2.6

3.4

—

Other and unspecified disorders of skin and subcutaneous tissue

3.40

8.07

1.5

1.8

—

Meningitis

4.03

8.07

1.7

—

Malignant neoplasm of oropharynx, including Hilmo

10.18

8.05

1.5

3.3

—

Lower back pain or/and sciatica

288

1293

1.46

8.05

2.2

2.0

—

Diplopia

187

2.53

8.04

1.7

2.0

—

Iridocyclitis

347

2.08

7.89

2.0

2.2

—

Polyneuropathies and other disorders of the peripheral nervous system

328

2.11

7.84

2.3

2.0

—

Myeloproliferative diseases

100

3.12

7.82

2.5

2.0

—

Anterior Iridocyclitis

309

2.14

7.80

2.0

2.1

—

Suppurative and necrotic conditions of lower respiratory tract

3.80

7.80

1.7

2.3

—

Suppurative and unspecified otitis media

107

522

1.82

7.79

1.9

2.1

—

Malignant neoplasm of small intestine, including Hilmo

9.48

7.79

2.4

3.1

—

Dermatopolymyositis

15.29

7.74

1.8

2.4

—

Systemic sclerosis (FG)

7.51

7.69

2.4

1.7

—

Coronary revascularization (ANGIO or CABG)

211

839

1.54

7.69

1.8

2.1

—

Erythema nodosum

7.48

7.68

2.1

—

Colorectal cancer

147

2.67

7.64

1.8

2.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

18.74

7.63

1.6

2.8

—

Other ulcerative colitis

3.74

7.63

1.2

2.2

—

Other disorders of ear

251

1113

1.48

7.61

2.1

2.0

—

Disorders of skin appendages

137

819

1.67

7.61

2.0

—

COPD (mode)

216

2.22

7.55

1.5

2.0

—

Other viral diseases, not elsewhere classified

267

2.21

7.54

2.4

2.1

—

Other ill-defined and unspecified causes of mortality

3.40

7.52

1.6

2.4

—

Concussion

120

562

1.74

7.51

1.9

2.0

—

Benign neoplasms

272

1028

1.46

7.50

1.9

2.0

—

Systemic sclerosis, icd10

7.20

7.50

2.4

1.7

—

Vasculitis limited to skin, not elsewhere classified

7.19

7.50

2.5

1.5

—

Crohn's disease of large intestine

3.68

7.46

1.4

2.0

—

Malignant neoplasm of endocrine gland

3.91

7.43

1.6

2.4

—

Other diseases of lip and oral mucosa

112

640

1.75

7.37

1.8

2.1

—

Fitting and adjustment of other devices

400

1.92

7.37

2.1

2.2

—

Malignant neoplasm of prostate, including Hilmo

138

2.37

7.37

1.7

2.5

—

IBD patients in KELA-register

343

2.05

7.37

1.6

2.1

—

Other and unspecified vasculitis limited to skin

8.45

7.33

2.5

1.4

—

Crohn disease

197

2.40

7.24

2.3

2.1

—

Disturbances of skin sensation

428

1.92

7.23

2.4

2.0

—

Nerve, nerve root and plexus disorders

285

1222

1.43

7.22

1.9

2.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

133

795

1.66

7.19

2.4

2.0

—

Disorders of magnesium metabolism

20.68

7.18

1.5

1.8

—

Other forms of systemic lupus erythematosus

20.58

7.18

2.5

3.6

—

Cholelithiasis, broad definition with cholecystitis

228

1034

1.49

7.16

2.0

—

Acute and subacute iridocyclitis

287

2.13

7.16

2.0

2.1

—

Disorders of oesophagus in diseases classified elsewhere

8.03

7.13

1.1

1.6

—

Unspecified nephritic syndrome

8.02

7.12

2.1

1.8

—

Malignant cancer of tonsil and base of tongue, including Hilmo

8.01

7.12

1.5

2.8

—

Exfoliative dermatitis

12.32

7.12

2.3

1.4

—

Osteonecrosis due to drugs

12.26

7.11

1.3

1.5

—

Raynaud syndrome

117

2.84

7.10

1.9

2.0

—

Malignant melanoma, including Hilmo

117

2.83

7.09

1.6

2.1

—

Epilepsy

465

1.87

7.07

2.1

2.0

—

Disorders of choroid and retina

215

1022

1.50

7.07

1.9

2.0

—

Non-small cell lung cancer, adenocarcinoma

6.04

7.07

1.6

2.8

—

Atrial fibrillation and flutter with reimbursement

210

2.10

7.06

2.0

2.2

—

Collagenous colitis

123

2.78

7.05

2.1

—

Other diseases of hard tissues of teeth

146

455

1.66

7.02

2.2

1.8

—

Nephrotic syndrome

7.03

7.01

2.5

1.7

—

Other problems related to primary support group, including family circumstances

148

2.57

6.95

2.7

2.1

—

Later onset COPD, excluding more controls

128

2.54

6.95

1.6

2.1

—

Hypothyroidism, drug reimbursement

3.05

6.93

1.8

1.9

—

Diseases of the myoneural junction and muscle

165

2.50

6.90

1.6

2.0

—

Other and unspecified tonsillitis

386

1.88

6.89

2.3

2.1

—

Sequelae of external causes of morbidity and mortality

409

1.91

6.81

2.6

2.0

—

In situ neoplasms

100

568

1.76

6.76

1.7

2.0

—

Ulcerative colitis

355

1.98

6.74

1.5

2.1

—

malignant neoplasm of male genital organs

145

2.27

6.67

1.7

2.4

—

Cholelithiasis

216

1010

1.48

6.63

2.0

—

Malignant neoplasm of stomach, including Hilmo

6.43

6.63

1.4

3.3

—

Other and unspecified follicular disorders

4.03

6.63

2.9

2.2

—

Pyothorax

4.03

6.63

1.7

1.9

—

Malignant neoplasm of breast, HER-positive

191

2.21

6.62

1.7

1.9

—

Ill-defined and unknown causes of mortality

3.05

6.61

1.6

2.2

—

Polyarteritis nodosa and related conditions

12.45

6.60

2.2

3.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

5.89

6.60

1.6

3.0

—

Use of amantadine

10.17

6.55

2.1

1.7

—

Other disorders of kidney and ureter

182

2.37

6.52

2.3

2.0

—

Abnormal results of function studies

106

2.84

6.51

1.8

2.2

—

GI-bleeding

451

1.84

6.51

1.9

2.0

—

Early onset COPD, excluding more controls

164

2.44

6.48

1.5

2.0

—

Other dialysis

6.23

6.48

2.0

1.5

—

Sixth [abducent] nerve palsy

5.73

6.46

2.5

1.8

—

Ulcerative colitis, NAS

208

2.27

6.44

1.6

2.0

—

Myalgia

368

1.93

6.44

2.1

—

Malignant neoplasm of heart, mediastinum and pleura

14.55

6.42

1.9

1.7

—

Pneumothorax

3.40

6.41

1.7

2.4

—

Viral and other specified intestinal infections

299

2.03

6.41

2.4

2.0

—

Inflammatory bowel disease, strict (require KELA)

362

1.94

6.39

1.6

2.1

—

Gastric ulcer

241

2.16

6.38

2.2

2.0

—

Paroxysmal tachycardia

243

2.07

6.37

1.5

2.2

—

Intestinal malabsorption

3.75

6.36

2.2

2.0

—

Other general symptoms and signs

3.90

6.34

1.2

2.0

—

Neuromuscular dysfunction of bladder

119

2.70

6.33

2.0

2.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

5.19

6.32

2.2

2.1

—

Dermatopolymyositis (FG)

11.20

6.32

1.6

1.8

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

+∞

6.32

1.7

0.0

—

Iridocyclitis in diseases classified elsewhere

9.36

6.30

1.5

1.8

—

Abnormality of white blood cells, not elsewhere classified

18.47

6.30

3.0

2.4

—

Other embolism and thrombosis

173

2.38

6.27

1.7

2.2

—

Major coronary heart disease event

218

901

1.46

6.26

1.8

2.1

—

Arthropathies

240

843

1.44

6.24

2.1

—

Genitourinary diseases

159

506

1.58

6.24

2.5

2.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

194

2.15

6.22

1.7

1.9

—

Pain (limb, back, neck, head abdominally)

190

630

1.51

6.20

2.4

1.9

—

Emergency coronary revascularization (for ACS)

220

920

1.46

6.19

1.8

2.1

—

Carcinoma in situ of skin of other and unspecified parts of face

3.06

6.19

1.7

2.0

—

Drug-induced cataract

6.34

6.18

2.0

1.3

—

Benign neoplasm: Skin of trunk

3.98

6.17

2.1

1.7

—

Mood disorders

273

1267

1.40

6.17

2.1

2.0

—

Subjective visual disturbances

388

1.89

6.16

2.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

146

911

1.56

6.15

1.8

2.0

—

Hydronephrosis

133

2.57

6.10

2.9

2.1

—

Adjustment and management of implanted device

194

2.27

6.10

1.3

2.3

—

Malignant neoplasm of prostate

129

2.28

6.08

1.6

2.4

—

Polyuria

348

1.93

6.07

2.0

—

Mood disorders, excluding more controls

253

1070

1.41

6.06

2.1

1.9

—

Myeloproliferative diseases (CML excluded)

2.89

6.04

2.6

2.0

—

Pericarditis

5.20

6.01

2.6

2.5

—

Cutaneous abscess, furuncle and carbuncle

399

1.86

5.99

2.3

2.2

—

Mood [affective] disorders

271

1266

1.39

5.97

2.1

2.0

—

Other and unspecified polyneuropathies, also in other diseases

282

2.03

5.93

2.3

2.0

—

Benzodiazepine use

265

1314

1.39

5.93

2.2

2.0

—

Other inflammatory liver diseases

3.06

5.91

2.7

1.9

—

Depression

254

1231

1.40

5.91

2.1

2.0

—

Other noninfective disorders of lymphatic vessels and lymph nodes

4.03

5.90

2.4

1.7

—

Misadventures to patients during surgical and medical care

204

2.21

5.86

1.9

2.0

—

Preparatory care for dialysis

3.81

5.82

2.1

1.5

—

Universal erythroderma, KELA reimbursement

11.29

5.81

2.0

1.8

—

Other and unspecified haemorrhagic conditions

11.27

5.81

1.6

2.6

—

Secondary malignant neoplasm of other and unspecified sites

11.27

5.81

1.4

1.3

—

Disorders of puberty, all

11.25

5.81

3.4

2.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.02

5.80

1.4

2.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

220

1.99

5.79

1.9

2.2

—

Polycystic ovarian syndrome, consortium definition

172

676

1.51

5.79

1.9

2.0

—

Carcinoma in situ of skin

2.87

5.77

1.6

2.1

—

Conduction disorders

324

1.86

5.76

1.8

1.9

—

Other arrhythmias

160

797

1.52

5.76

1.8

2.1

—

Other peripheral vascular diseases

108

2.70

5.75

1.9

2.2

—

Other specific joint derangements/joint disorders

188

826

1.47

5.72

1.9

2.1

—

Other diseases of spinal cord

5.61

5.69

3.3

1.6

—

Crohn disease (strict definition, require KELA)

2.98

5.68

1.4

2.1

—

Abnormal findings on examination of urine, without diagnosis

3.72

5.65

2.1

2.0

—

Malignant neoplasm of thyroid gland

3.71

5.64

1.3

1.8

—

Gout, unspecified

281

2.00

5.63

1.8

1.9

—

Disease of hard tissues of teeth, NOS

136

448

1.59

5.62

2.0

1.8

—

Nonpyogenic thrombosis of intracranial venous system

13.15

5.61

3.0

1.7

—

Localized skin eruption due to drugs and medicaments

13.10

5.60

2.1

2.0

—

Acute nasopharyngitis (common cold)

132

2.49

5.60

2.2

—

Amyloidosis, other/unspecified

8.58

5.57

1.3

1.4

—

Spondyloarthritis

202

2.18

5.57

1.6

2.1

—

Viral and other specified intestinal infections

415

1.79

5.56

2.2

2.0

—

Dermatophytosis

177

2.27

5.54

1.8

2.0

—

Disorders of conjunctiva

212

1200

1.42

5.53

2.0

—

Obesity due to excess calories

125

797

1.57

5.52

1.8

2.1

—

Special screening examination for other diseases and disorders

140

2.44

5.51

1.7

1.9

—

Spondylopathies

205

851

1.44

5.51

1.9

2.0

—

Lung transplant status

16.42

5.44

2.4

1.4

—

Lung transplantation

16.42

5.44

2.4

1.4

—

Systemic sclerosis,strict definition

16.34

5.43

2.8

1.8

—

Asthma/COPD (KELA code 203)

242

1196

1.39

5.43

1.9

2.0

—

Melanocytic naevi

471

1.75

5.43

1.7

2.1

—

Scleritis

16.24

5.42

3.0

2.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

320

1.91

5.41

1.8

2.0

—

Vulvovaginal ulceration/inflammation in other diseases

3.03

5.37

1.9

2.1

—

CR(E)ST syndrome

7.99

5.36

2.2

1.7

—

Alzheimer disease, including avohilmo

349

0.32

5.35

2.9

1.7

—

Special screening examination for infectious and parasitic diseases

222

1.96

5.34

1.6

1.9

—

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

+∞

5.30

2.4

0.0

—

Ascites

2.79

5.30

2.1

2.2

—

Retention of urine

429

1.71

5.29

2.0

1.9

—

Other diseases of the digestive system

453

1.75

5.27

1.9

2.0

—

Hyperparathyroidism

224

2.08

5.27

2.0

—

Heart failure and coronary heart disease

107

465

1.63

5.26

1.6

2.0

—

Insulin, fast-acting

581

1.65

5.25

2.1

2.0

—

Obesity related asthma

536

1.68

5.25

1.9

2.0

—

Pain in joint

145

607

1.52

5.24

2.0

1.9

—

ILD medications: nintedanib

+∞

5.23

1.4

0.0

—

Other antidepressants

271

1018

1.36

5.21

2.1

2.0

—

Other neurological diseases

180

979

1.45

5.21

2.2

2.0

—

Colon adenocarcinoma

3.05

5.21

2.0

2.3

—

Melanocytic naevi, other sites/unspecified

114

2.56

5.20

1.3

2.1

—

Other CVD (FINNGEN)

2.54

5.20

1.3

2.1

—

Fentanyl

108

2.60

5.19

1.9

—

Gastroduodenal ulcer

345

1.85

5.19

2.1

1.9

—

Testicular dysfunction

3.36

5.17

2.5

2.0

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2.81

5.14

1.4

2.1

—

Folate deficiency anaemia

13.60

5.10

2.5

1.3

—

Guillain-Barre syndrome

8.45

5.07

2.9

2.1

—

Isolated proteinuria

5.71

5.07

2.3

1.8

—

Postmenopausal osteoporosis with pathological fracture

3.09

5.06

2.0

1.4

—

Malignant melanoma

2.66

5.06

1.7

2.2

—

Malignant melanoma of skin, including Hilmo

2.66

5.06

1.5

2.2

—

Other and unspecified acquired haemolytic anaemias

10.23

5.05

1.3

1.6

—

Coxarthrosis [arthrosis of hip](FG)

123

555

1.56

5.05

2.0

1.9

—

Infections with a predominantly sexual mode of transmission

496

1.69

5.04

2.6

2.0

—

Myocarditis

3.57

5.04

1.4

2.4

—

Testicular hypofunction

3.43

5.03

2.5

2.1

—

Sleep apnoea

241

1139

1.37

5.00

1.8

2.1

—

Other follicular disorders

2.70

5.00

2.4

2.1

—

Paralytic ileus and intestinal obstruction

372

1.80

5.00

1.9

—

Nonischemic cardiomyopathy

117

2.49

4.94

2.2

2.3

—

Other specified and unspecified retinal disorders

3.69

4.93

1.9

1.8

—

Gingivitis and periodontal diseases

264

1005

1.36

4.92

2.1

2.0

—

Conjunctivitis

190

1124

1.41

4.92

2.0

2.1

—

Acute posthaemorrhagic anaemia

6.04

4.91

2.3

1.6

—

Secondary right heart disease

5.45

4.91

2.4

1.6

—

Malignant neoplasm of stomach

6.03

4.91

1.3

3.9

—

Gout, idiopatic and unspecified

353

1.82

4.90

1.8

—

Other and unspecified visual disturbances

136

2.36

4.89

1.3

1.9

—

Malignant neoplasm, without specification of site

7.74

4.85

1.8

1.5

—

Vocal cord dysfunction

133

2.30

4.81

1.8

2.1

—

Benign neoplasm: Tonsil

11.61

4.80

1.1

1.9

—

Bell's palsy

169

2.20

4.80

1.6

2.2

—

Eosinophilic disease (BM)

11.56

4.79

2.0

2.1

—

Eosinophilia

11.56

4.79

2.0

1.6

—

Insulin, fast-acting or short human

597

1.61

4.76

2.1

—

All anxiety disorders

153

828

1.46

4.73

2.1

—

Conductive and sensorineural hearing loss

198

955

1.40

4.73

2.2

2.0

—

Disorders of vitreous body and globe

125

794

1.51

4.72

1.9

2.0

—

Budesonide

151

2.26

4.71

1.7

2.2

—

Attention to artificial openings

4.70

4.68

4.1

3.1

—

Otitis externa, unspecified

158

2.22

4.67

2.1

2.2

—

Emphysema

2.85

4.65

1.5

2.3

—

Diaphragmatic hernia

555

1.62

4.64

2.1

1.9

—

Convalescence

3.12

4.64

1.4

2.1

—

Other and unspecified effects of external causes

441

1.70

4.64

2.1

—

Infectious mononucleosis

103

2.53

4.62

2.2

2.1

—

Amyloidosis

6.18

4.61

1.3

1.4

—

Carcinoma in situ of skin of scalp and neck

6.17

4.61

1.5

1.6

—

Disorders of vitreous body

122

780

1.51

4.60

1.9

2.0

—

Malignant neoplasm of oral cavity, including Hilmo

5.48

4.60

1.9

2.5

—

Combined immunodeficiencies

14.21

4.59

2.7

1.8

—

Other pulmonary heart/vessel disease

4.54

4.55

2.5

2.0

—

Squamous cell neoplasms and carcinomas of the skin

4.53

4.54

1.5

2.7

—

Disorders of puberty

10.11

4.53

2.1

—

Other diseases of liver

276

1.89

4.52

2.7

2.1

—

Hypothyroidism, other/unspecified

220

1061

1.36

4.51

1.9

2.0

—

Myositis

4.86

4.50

1.2

2.0

—

Hydrocele

148

2.24

4.49

1.9

2.0

—

Abnormalities of heart beat

496

1.64

4.48

1.5

2.0

—

Pain in limb

204

991

1.38

4.46

2.1

2.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

5.24

4.45

1.2

3.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

152

967

1.44

4.43

2.2

2.0

—

Intermittent heterotropia

2.93

4.43

3.3

2.2

—

Coeliac disease

175

2.12

4.43

1.5

2.2

—

Periodontitis

242

1209

1.34

4.42

2.2

2.0

—

Varicella [chickenpox]

3.02

4.40

2.8

1.9

—

Chronic suppurative otitis media, including avohilmo

2.56

4.38

1.8

2.1

—

Other joint disorders

218

841

1.37

4.37

1.9

2.1

—

Cholangitis (primary sclerosing, PSC)

2.89

4.33

1.8

—

Juvenile arthritis (FINNGEN)

3.35

4.32

1.9

2.5

—

Pyogenic arthritis

2.66

4.32

2.3

1.9

—

Personal history of medical treatment

9.05

4.30

1.4

1.9

—

Polycythaemia vera

6.29

4.29

2.9

3.1

—

Exclusion endpoint for clefts

6.30

4.29

2.8

—

Drug-induced polyneuropathy

11.89

4.29

1.9

2.8

—

Hypoplasia of dental enamel

11.82

4.28

6.1

2.5

—

Scleritis and episcleritis

2.71

4.25

2.3

2.1

—

Abnormal weight loss

120

2.34

4.24

3.2

2.1

—

Cardiomyopathy

212

1.99

4.24

1.6

1.8

—

Malignant neoplasm of corpus uteri, including Hilmo

3.04

4.23

1.9

1.7

—

Exclusions for E4_PCOS_CONSORTIUM

175

783

1.40

4.19

2.1

—

Chronic periodontitis, including avohilmo

240

1211

1.33

4.18

2.2

2.0

—

Molar incisor enamel hypoplasia

4.85

4.17

4.3

2.3

—

Other retinal disorders

150

819

1.43

4.15

1.9

2.0

—

Psoriatic and enteropathic arthropathies

160

2.13

4.14

1.4

2.2

—

Status epilepticus

4.36

4.13

2.6

1.5

—

Temporomandibular joint disorders, including avohilmo

110

721

1.51

4.13

1.9

2.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

222

1086

1.34

4.12

1.9

2.0

—

Weight loss

128

2.27

4.12

3.1

2.0

—

Malignant neoplasm of thyroid gland, including Hilmo

2.99

4.12

1.3

2.2

—

Other disorders of optic [2nd] nerve and visual pathways

2.81

4.12

2.9

1.8

—

Soft tissue disorders

263

1029

1.32

4.11

2.0

—

Phlebitis and thrombophlebitis (not including DVT)

344

1.75

4.10

2.0

—

Use of anticholinesterases

362

0.39

4.10

2.9

1.7

—

N06DA Anticholinesterases

362

0.39

4.10

2.9

1.7

—

Childhood asthma (age<16)

2.35

4.10

2.1

—

Inflammatory diseases of female pelvic organs

140

713

1.44

4.09

1.6

2.1

—

Campylobacter enteritis

4.66

4.06

2.2

1.8

—

Other nutritional deficiencies

164

1110

1.39

4.05

1.8

2.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

251

1.88

4.05

2.3

2.1

—

Disorder of the sleep-wake schedule

5.06

4.01

1.9

2.7

—

Childhood asthma (age<16), excluding more controls

2.33

4.01

2.1

—

Haemorrhage, not elsewhere classified

5.03

4.00

1.4

2.0

—

Colorectal adenocarcinoma

123

2.27

4.00

1.7

2.0

—

Bronchitis, not specified as acute or chronic

111

2.35

3.99

2.2

2.1

—

Intestinal stricture

484

1.61

3.98

1.8

2.0

—

Non-small cell lung cancer, squamous

6.45

3.98

1.2

4.7

—

Hypocalcemia

5.61

3.98

1.7

1.9

—

Other coagulation defects

2.60

3.97

2.9

2.0

—

Paralytic strabismus

2.54

3.96

2.2

2.3

—

Irregular menses

112

592

1.50

3.96

2.1

2.0

—

Dentofacial anomalies [including malocclusion]

173

1009

1.38

3.94

2.1

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

147

993

1.41

3.94

2.1

—

Rheumatism, unspecified

191

2.00

3.91

1.5

2.0

—

Anxiety (asthma-related co-morbidities)

152

836

1.41

3.91

2.1

2.0

—

Benign neoplasm of thyroid gland

4.09

3.90

1.9

1.8

—

Faecal incontinence

100

2.41

3.88

1.4

1.7

—

Adverse effects, not elsewhere classified

313

1.76

3.88

2.1

2.2

—

Cystitis

201

885

1.35

3.87

2.2

2.0

—

Other specified congenital malformation syndromes affecting multiple systems

7.34

3.86

3.3

3.5

—

Degenerative diseases of the nervous system

349

0.42

3.85

2.6

1.8

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

277

1.81

3.85

2.0

2.2

—

Keratitis

575

1.55

3.85

2.1

—

Diseases of inner ear

126

845

1.44

3.84

1.9

2.0

—

Disorders of refraction and accommodation

410

1.66

3.84

2.3

2.1

—

Diseases of male genital organs

134

465

1.46

3.82

2.2

2.1

—

Viral encephalitis, not elsewhere classified/unspecified

6.06

3.82

3.9

1.6

—

Infections with a predominantly sexual mode of transmission

100

617

1.51

3.82

2.4

2.0

—

Malignant neoplasm of tongue, including Hilmo

6.04

3.82

1.9

1.5

—

Disorders of vestibular function (Vertigo)

108

717

1.48

3.80

1.9

2.0

—

Ulcerative enterocolitis

3.97

3.80

1.9

2.0

—

Pleural plaque

2.48

3.79

2.3

2.0

—

Benign neoplasm of other and unspecified intrathoracic organs

8.88

3.78

1.9

1.8

—

Insulin medication

152

917

1.40

3.78

2.2

2.0

—

Osteopathy in diseases classified elsewhere

12.24

3.78

1.8

1.4

—

Spondylopathies (FG)

194

1.96

3.76

1.6

2.2

—

Unspecified misadventure during surgical and medical care

2.74

3.75

1.6

1.8

—

Cerebral cysts

2.74

3.75

2.3

1.8

—

Otitis externa

339

1.71

3.74

2.0

2.2

—

Necrosis of pulp, including avohilmo

145

1035

1.40

3.74

2.0

—

Cramp and spasm

2.93

3.74

3.6

1.8

—

Malignant neoplasm of bladder

4.59

3.74

1.9

3.3

—

Injury, poisoning and certain other consequences of external causes

140

489

1.44

3.73

2.1

2.0

—

Other/unspecified dorsalgia

598

1.53

3.73

2.2

1.9

—

Cholecystectomy

164

1031

1.37

3.72

2.0

—

Otalgia

2.41

3.72

1.9

2.1

—

Other juvenile arthritis

3.61

3.70

1.9

2.4

—

Carcinoma in situ of skin of trunk

5.03

3.69

1.2

1.6

—

Crohn disease (strict definition, all UC cases excluded)

2.80

3.69

1.4

2.0

—

Hypersensitivity pneumonitis due to organic dust

6.74

3.68

2.0

1.8

—

Inflammation of lacrimal passages (acute and unspecified)

6.73

3.68

2.0

2.1

—

Malignant neoplasm of liver and intrahepatic bile ducts

6.70

3.67

1.3

3.7

—

Ankylosing spondylitis, ICD10

135

2.16

3.66

1.8

2.1

—

Primary ovarian failure

5.68

3.66

3.1

2.4

—

Congenital malformations of the respiratory system

5.68

3.66

3.4

2.6

—

Elevated blood glucose level

103

2.34

3.66

3.3

2.3

—

Diseases of salivary glands

511

1.57

3.66

2.6

2.0

—

Polymyalgia rheumatica

155

2.07

3.66

1.7

2.1

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

2.70

3.65

1.6

2.0

—

Other epidermal thickening

3.13

3.65

2.2

2.0

—

Other salmonella infections

3.13

3.65

2.0

1.9

—

Alzheimer disease

287

0.38

3.64

3.1

1.7

—

Other obstetric conditions, not elsewhere classified

300

1.61

3.63

2.3

2.0

—

Syphilis

4.44

3.63

4.6

1.9

—

Syphilis

4.44

3.63

4.6

1.9

—

Small fibre neuropathy

4.43

3.63

2.5

1.6

—

Amenorrhoea

2.48

3.63

2.0

2.1

—

Atopic dermatitis, strict definition with reimbursement

441

1.60

3.62

2.7

2.1

—

Congenital malformations of great arteries

5.57

3.61

2.8

3.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

331

1.65

3.56

1.6

1.9

—

Vascular disorders of the intestines

2.66

3.56

1.1

2.0

—

Varicella [chickenpox]

2.66

3.56

2.8

1.9

—

Focal epilepsy

322

1.71

3.54

2.0

2.1

—

Disorders of the thyroid gland

231

1157

1.30

3.52

1.9

2.0

—

Isolated growth hormone deficiency

10.20

3.51

4.5

3.5

—

External causes of morbidity and mortality

167

609

1.38

3.51

2.0

—

Malignant neoplasm of oral cavity

5.32

3.51

1.8

2.8

—

Abscess of lung

6.22

3.51

1.9

1.5

—

Optic atrophy

6.21

3.51

3.5

1.5

—

Other crystal arthropathies

6.21

3.51

1.3

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

501

1.56

3.50

2.5

2.0

—

Other salmonella infections

3.63

3.50

2.1

1.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

196

997

1.33

3.49

1.9

2.0

—

Unspecific neurodegenerative disorder

413

0.51

3.47

2.3

1.8

—

Chronic ulcer of skin, not elsewhere classified

2.48

3.46

1.5

2.1

—

Sleep apnoea, including avohilmo

244

1173

1.29

3.45

1.9

2.1

—

Ocular pain

106

2.27

3.45

1.6

2.2

—

Cutaneous lupus erythematosus

4.58

3.43

2.0

—

Other and unspecified epidermal thickening

4.58

3.43

2.2

2.4

—

Vitreous haemorrhage

139

2.09

3.42

1.8

2.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

408

1.61

3.42

2.2

2.0

—

Fissure and fistula of anal and rectal regions

372

1.64

3.40

1.6

2.0

—

Endocarditis

4.10

3.39

1.9

2.8

—

Visual field defects

107

2.25

3.38

1.8

2.2

—

Chronic Coagulation defects

5.04

3.37

2.9

2.6

—

Heart failure and bmi 25plus

358

1.55

3.37

1.9

—

Adult respiratory distress syndrome

7.08

3.37

1.7

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

286

1.60

3.36

2.1

—

Speech therapy

412

1.61

3.35

1.9

2.0

—

Benign neoplasm: Other and unspecified parts of small intestine

5.78

3.35

1.4

1.6

—

Crystal arthropathies, rheuma endpoint

5.77

3.35

1.3

1.2

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

5.76

3.34

1.9

1.5

—

Disorders of lipoprotein metabolism and other lipidaemias

187

871

1.33

3.34

1.8

2.0

—

Diverticular disease of intestine

167

789

1.35

3.34

2.0

1.9

—

Colectomy operation

239

1.80

3.33

1.9

2.1

—

Missing teeth due to accident, extraction or parodontitis

140

959

1.38

3.31

2.1

2.0

—

Otitis media, unspecified

129

2.08

3.31

2.9

2.1

—

Accidents

213

814

1.31

3.31

2.2

2.1

—

Phobic anxiety disorders

175

1.94

3.31

2.3

2.2

—

Pneumonitis due to solids and liquids

2.42

3.30

2.4

2.3

—

Hyperfunction of pituitary gland

2.93

3.30

2.7

2.0

—

Chronic suppurative otitis media

2.48

3.29

1.9

2.2

—

Primary adrenocortical insufficiency

8.67

3.27

2.3

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

8.64

3.27

2.3

1.3

—

Injuries to the knee and lower leg

292

1293

1.25

3.26

1.8

2.1

—

Spondylosis

131

768

1.39

3.25

2.0

1.9

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

447

1.57

3.25

2.1

—

Paraplegia, diplegia of upper limbs

4.78

3.24

3.4

1.5

—

Juvenile rheumatoid arthirtis

4.77

3.24

2.4

2.1

—

Essential (haemorrhagic) thrombocythaemia

4.76

3.24

1.7

2.8

—

Dorsopathies

256

1022

1.27

3.22

2.2

2.0

—

Early syphilis

5.40

3.20

4.9

2.1

—

Astigmatism

2.58

3.20

2.8

2.1

—

Psoriasis (vulgaris), strict definition

3.55

3.20

1.8

2.2

—

Chronic hepatitis, not elsewhere classified

3.55

3.20

1.9

1.6

—

Coxarthrosis

112

516

1.43

3.20

2.1

2.0

—

Congenital malformations of the respiratory system

5.38

3.19

3.5

2.7

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

136

991

1.37

3.19

1.9

2.0

—

Other or unspecified ileus, impaction or obstruction

257

1.75

3.19

2.1

1.9

—

Dislocation, sprain and strain of joints and ligaments of head

2.87

3.19

1.9

2.1

—

Ulcer of lower limb, not elsewhere classified

199

1.86

3.19

1.4

2.0

—

Diseases of arteries, arterioles and capillaries

155

848

1.35

3.17

1.9

2.0

—

Other gastritis (incl. Duodenitis)

333

1.65

3.17

2.2

2.0

—

Stomatitis and related lesions

303

1.69

3.16

1.8

2.0

—

Ankylosing spondylitis

144

2.02

3.15

1.8

1.9

—

Motor disorders, excluding more controls

8.17

3.15

2.7

—

Somatoform disorder

229

1.79

3.14

2.3

2.1

—

Focal epilepsy, strict definition

296

1.69

3.14

1.8

2.2

—

Other diseases of stomach and duodenum

2.42

3.13

2.0

1.9

—

Gout, strict definition

259

1.74

3.12

1.9

—

Other misadventures during surgical and medical care

4.54

3.12

2.3

2.0

—

Temporal arteritis

3.45

3.11

2.1

1.5

—

Excessive, frequent and irregular menstruation

347

1.49

3.10

2.0

—

Hypoplasia of dental enamel , including avohilmo

4.07

3.10

4.9

2.3

—

Allergic purpura

3.69

3.09

2.6

2.1

—

Unspecified chronic bronchitis

4.02

3.08

1.3

2.0

—

Crohn's disease of small intestine

2.33

3.07

1.8

2.1

—

Other Crohn's disease

2.33

3.07

2.8

2.3

—

Strabismus

413

1.57

3.07

2.7

2.2

—

Malignant neoplasm of other and unspecified parts of tongue

7.57

3.06

1.3

1.5

—

L04AC Interleukin inhibitors

2.39

3.06

1.8

2.1

—

Other diseases of biliary tract

2.23

3.05

1.9

2.1

—

Malnutrition

5.04

3.05

1.8

2.1

—

5.03

3.05

2.8

1.7

—

Other symptoms and signs involving the urinary system

146

1.99

3.04

2.0

2.2

—

Episcleritis

2.51

3.04

2.2

2.0

—

Internal derangement of knee

597

1.47

3.04

1.8

2.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

167

1.92

3.03

2.8

1.9

—

Thyroiditis, ILD-related definition

119

2.11

3.03

1.5

2.1

—

Sensorineural hearing loss

177

913

1.32

3.03

2.2

2.0

—

Outcome of delivery

145

0.34

3.03

2.4

2.1

—

Nystagmus and other irregular eye movements

5.89

3.03

2.0

2.6

—

Other dorsopathies, not elsewhere classified

246

1016

1.27

3.02

2.2

2.0

—

Giant cell arteritis with polymyalgia rheumatica

3.35

3.02

2.1

1.5

—

Golimumab

3.35

3.02

1.8

2.3

—

Nonspecific lymphadenitis

2.31

3.00

2.3

2.0

—

Unequal limb length (acquired)

10.11

2.98

2.8

1.8

—

Benign neoplasm: Bladder

10.11

2.98

1.0

1.8

—

Polycystic kidney disease

3.87

2.98

1.9

1.7

—

Other and unspecified psoriasis

2.36

2.98

1.6

2.1

—

Other diseases of blood and blood-forming organs

2.41

2.96

2.0

1.7

—

Recurrent or chronic depression

101

495

1.44

2.96

1.7

1.9

—

Speech disturbances, not elsewhere classified

101

2.19

2.92

2.0

2.1

—

Spontaneous rupture of synovium and tendon

121

2.07

2.92

1.7

2.3

—

Use of donepezil

215

0.36

2.91

1.9

1.8

—

Diabetes, varying definitions

249

1163

1.26

2.90

1.9

2.1

—

Any dementia

385

0.54

2.89

2.4

1.8

—

Alzheimer’s disease, strict definition

230

0.36

2.89

4.0

1.7

—

Myopia

170

1.89

2.89

2.1

2.2

—

Vitamin deficiency

2.70

2.89

1.6

2.0

—

Vitamin deficiency, wide

2.70

2.89

1.6

2.0

—

Other and unspecified coagulation defects

2.70

2.89

3.0

2.3

—

Other external causes of accidental injury

209

814

1.29

2.88

2.1

—

Use of memantine

255

0.39

2.88

3.5

1.7

—

Use of other anti-dementia drugs

255

0.39

2.88

3.5

1.7

—

242

1.71

2.88

2.0

1.8

—

Pacemaker

441

1.52

2.88

1.6

1.9

—

Allergic asthma (mode)

216

1.77

2.88

2.0

2.1

—

Other chondrocalcinosis

6.74

2.87

1.0

1.6

—

Ovarian dysfunction

2.25

2.86

2.6

2.4

—

Unspecified haematuria

577

1.42

2.86

1.9

—

Ulcerative colitis (strict definition, require KELA)

259

1.70

2.85

1.7

2.1

—

Acute alcohol intoxication

416

0.48

2.85

2.5

2.0

—

Giant cell arteritis

3.17

2.85

2.1

1.5

—

Cerebral palsy and other paralytic syndromes

157

1.92

2.84

2.7

2.2

—

Obesity and other hyperalimentation

149

1084

1.33

2.83

1.8

2.0

—

Malignant melanoma of skin

2.34

2.81

1.6

2.3

—

Other erythematous conditions

3.35

2.81

1.5

1.8

—

Congenital malformations, deformations and chromosomal abnormalities

153

1069

1.32

2.81

2.2

2.0

—

Asthma mixed form (mode)

3.34

2.81

1.3

2.2

—

Viral hepatitis

103

2.14

2.80

4.5

2.1

—

Any mental disorder

271

1093

1.24

2.80

2.4

1.9

—

Other viral hepatitis

2.23

2.80

4.8

2.1

—

Crowding of teeth, including avohilmo

2.17

2.79

3.0

2.2

—

Other sleep disorders

158

1.90

2.79

2.0

—

Other or ill-defined heart diseases

2.65

2.79

1.5

1.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

2.47

2.78

1.7

—

Other metabolic disorders

187

1.82

2.78

2.9

1.9

—

Enteropathic arthropathies

3.94

2.78

1.7

2.0

—

Retinal haemorrhage

3.94

2.78

2.1

1.5

—

Recurrent aphthous stomatitis , including avohilmo

209

1.77

2.77

1.4

2.1

—

Diabetes mellitus

249

1167

1.25

2.76

1.9

2.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

254

1.70

2.76

1.7

2.2

—

Allergic asthma (mode), excluding more controls

219

1.74

2.76

2.0

2.1

—

Crystalline deposits in vitreous body

8.44

2.76

1.2

1.7

—

Use of galantamine

0.00

2.75

0.0

2.1

—

Cardiomyopathies, Primary/intrinsic

145

1.94

2.74

1.6

1.8

—

Oxicams

219

1.58

2.74

2.1

1.9

—

Early syphilis

5.06

2.74

5.4

1.9

—

Panhypopituitarism

5.04

2.73

3.0

1.6

—

Vitamin D deficiency

5.04

2.73

1.6

2.4

—

Cystic kidney disease

3.26

2.73

1.8

—

Type 2 diabetes

237

1106

1.25

2.72

1.9

2.0

—

322

1.57

2.71

2.0

1.8

—

Benign neoplasm of urinary organs

2.72

2.71

1.5

—

DVT of lower extremities

263

1.68

2.71

2.3

2.0

—

Malignant neoplasm of corpus uteri

2.72

2.71

1.5

1.7

—

Any dementia, excluding more controls

373

0.55

2.70

2.4

1.8

—

Lagophthalmos

6.06

2.70

1.3

1.6

—

Pain associated with micturition

160

1.88

2.70

2.3

2.1

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

146

1.92

2.69

1.6

2.4

—

Congenital iodine-deficiency syndrome/hypothyroidism

3.47

2.69

1.0

1.7

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

279

1.65

2.69

1.7

2.1

—

Obesity

147

1078

1.32

2.69

1.7

2.0

—

Psychiatric diseases

250

1005

1.25

2.68

2.3

1.9

—

Erythema multiforme

4.24

2.68

2.8

2.3

—

Autonomic disorders

4.24

2.68

2.6

1.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified

318

1.61

2.68

2.2

2.1

—

Pleural plaque with presence of asbestos

2.29

2.67

2.6

2.1

—

Symptoms and signs involving speech and voice

535

1.46

2.66

2.0

2.1

—

Aortic aneurysm

305

1.61

2.65

1.9

1.8

—

Benign neoplasm: Small intestine

2.81

2.65

1.7

1.5

—

Gingival hyperplasia

3.16

2.64

3.2

2.1

—

Papillary adenocarcinoma of thyroid gland

3.15

2.64

1.4

1.6

—

Dementia

448

0.60

2.63

2.2

1.8

—

Hypermobility syndrome

2.47

2.62

2.3

2.2

—

Ankylosing spondylitis, strict definition

2.56

2.61

2.1

2.0

—

Alopecia areata

3.36

2.60

2.1

1.6

—

Moderate visual impairment, binocular

4.69

2.60

2.3

1.4

—

Other anxiety disorders

103

645

1.39

2.59

1.9

2.0

—

Papilloedema, unspecified

4.03

2.57

2.6

2.0

—

Familial hypercholesterolemia

207

1.74

2.56

2.7

1.8

—

Benign neoplasm: Skin, unspecified

3.07

2.56

1.5

1.8

—

Asthma mixed form (mode), excluding more controls

3.06

2.56

1.3

2.2

—

Mandibular retrognathia

2.30

2.56

1.8

2.5

—

Right ventricular outflow tract obstruction

7.24

2.56

1.8

3.4

—

Arthropathy in Crohn disease

7.22

2.55

1.6

2.0

—

Vitiligo

7.21

2.55

1.4

3.1

—

Obsessive-compulsive disorder

2.36

2.55

2.3

2.1

—

Other nutritional anaemias

7.21

2.55

4.0

1.7

—

Intracranial and intraspinal abscess and granuloma

5.51

2.55

1.8

—

Toxic liver disease

5.50

2.55

1.0

2.0

—

Portal vein thrombosis

5.50

2.55

1.8

1.5

—

Non-selective monoamine reuptake inhibitors

584

1.42

2.55

1.6

1.9

—

Depression or dysthymia

170

726

1.29

2.53

2.3

1.9

—

Dementia, including avohilmo

493

0.63

2.51

2.1

1.8

—

AV-block

188

1.73

2.51

1.7

1.9

—

COPD, hospital admission 2, with asthma infections

400

1.48

2.49

1.6

1.9

—

Cystic kidney disease

2.99

2.49

1.8

—

Acute laryngitis and tracheitis

134

1.91

2.48

1.7

2.3

—

Acute nephritic syndrome

4.40

2.48

1.3

1.9

—

Other and unspecified diseases of blood and blood-forming organs

4.40

2.47

2.0

1.4

—

Diseases of external ear

552

1.43

2.47

2.0

—

Open wound of lower leg

217

1.71

2.47

1.4

2.1

—

Injuries to the wrist and hand

241

1357

1.23

2.47

2.0

—

Other conjunctival vascular disorders and cysts

3.83

2.46

2.8

2.0

—

Bullous disorders

2.47

2.45

1.4

1.8

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

132

792

1.32

2.44

2.2

2.0

—

Anogenital herpesviral [herpes simplex] infection

2.24

2.44

2.5

2.2

—

Cardiomyopathy (excluding other)

159

1.83

2.43

1.6

1.8

—

Other diseases of anus and rectum

438

1.48

2.43

1.5

1.9

—

Conotruncal defects

5.05

2.41

3.8

3.3

—

Other mycoses, not elsewhere classified/unspecified

5.04

2.40

1.5

1.9

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

5.03

2.40

1.5

1.8

—

Malignant neoplasm of tongue

5.03

2.40

1.3

—

Orchitis and epididymitis

124

1.94

2.39

1.7

2.0

—

Cardiomyopathy, other and unspecified

2.12

2.38

1.8

2.0

—

Cushing syndrome

6.31

2.38

1.2

1.9

—

Family history of other specific disorders

6.30

2.37

1.2

2.0

—

Parapsoriasis

6.28

2.37

1.6

2.1

—

Oligomenorrhoea

2.51

2.36

1.9

1.7

—

Ulcerative ileocolitis

2.51

2.36

1.5

2.0

—

Other facial nerve disorders

3.05

2.36

2.4

1.8

—

Malignant neoplasm of pancreas, including Hilmo

2.61

2.35

2.0

2.3

—

Fibrosis and cirrhosis of liver

111

1.99

2.35

1.8

2.1

—

Cardiac arrest

2.45

2.35

1.4

2.2

—

Ingrowing nail

2.26

2.34

1.9

1.8

—

malignant neoplasm of female genital organs

2.05

2.33

1.7

1.9

—

Abnormal spermatozoa

169

1.78

2.32

2.0

—

Rosacea

169

1.78

2.32

1.8

1.9

—

Colonic or urogenital fistula

436

1.47

2.31

1.6

2.1

—

Osteomyelitis

2.19

2.31

1.5

2.2

—

Pleural plaque without asbestos

3.23

2.31

2.3

1.6

—

Vertigo of central origin

4.65

2.27

2.8

1.8

—

Optic atrophy

4.65

2.27

3.3

1.5

—

Primary biliary cholangitis (PBC)

4.64

2.27

1.7

1.9

—

Chromosomal abnormalities, not elsewhere classified

3.49

2.26

2.9

2.4

—

Other disorders of bone

293

1.57

2.26

2.0

2.2

—

Motor disorders

4.62

2.26

2.7

3.0

—

Fibromyalgia

134

1.87

2.26

2.3

2.1

—

Arthrosis

159

681

1.28

2.26

1.8

2.1

—

Other disorders of conjunctiva

208

1.69

2.26

2.3

2.1

—

Left hemicolectomy

3.91

2.25

1.6

1.3

—

Other congenital malformations of the digestive system

2.74

2.25

1.9

2.5

—

Scoliosis

113

1.95

2.25

1.7

1.9

—

Ovarian cyst

339

1.41

2.25

1.8

2.0

—

Seborrhoeic keratosis

342

1.52

2.23

1.7

2.0

—

Specific developmental disorder of motor function

4.54

2.23

2.7

3.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

226

1260

1.22

2.22

2.2

2.0

—

Monoplegia

5.59

2.21

1.8

1.7

—

Impotence

2.20

2.21

2.2

—

Deforming dorsopathies

441

1.45

2.19

1.8

1.9

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

516

1.42

2.19

2.3

2.1

—

Benign neoplasm: Pancreas

3.35

2.18

2.1

1.5

—

Aortic valve malfunction, age under 60 years

136

1.84

2.17

1.6

2.3

—

Postpartum haemorrhage due to anatomy

136

1.84

2.17

1.7

2.3

—

Other disorders of eye and adnexa

203

1.68

2.17

1.7

2.0

—

Entropion and trichiasis of eyelid

2.07

2.16

3.2

2.2

—

Spirochaetal infections, other/unspecified

129

1.87

2.16

1.9

2.1

—

Other diseases of upper respiratory tract

256

1104

1.21

2.16

2.1

2.0

—

Seronegative juvenile rheumatoid arthritis

4.31

2.15

2.5

2.7

—

Eustachian salpingitis and obstruction

108

1.95

2.15

2.3

—

Other abnormal uterine and vaginal bleeding

256

1.51

2.15

2.0

—

Abnormal involuntary movements

181

1.72

2.14

3.0

2.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

242

1.60

2.14

1.9

2.3

—

Neovascular glaucoma

2.79

2.14

1.6

1.9

—

Glaucoma secondary to other eye disorders

2.79

2.14

1.6

1.9

—

Disorders of psychological development

140

1.79

2.13

2.7

2.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.78

2.13

3.0

2.5

—

Type of accident

469

1.43

2.13

2.3

2.1

—

Cirrhosis of liver, NAS

2.21

2.11

1.9

2.1

—

Acute alcohol intoxication, ICD10

319

0.50

2.10

2.5

2.1

—

Procreative management

481

1.39

2.10

1.8

2.1

—

Irritable bowel syndrome

429

1.45

2.10

1.9

2.1

—

Suppurative otitis media, unspecified

3.21

2.09

1.3

2.0

—

Premature rupture of membranes

246

1.51

2.09

1.8

2.1

—

Short stature, not elsewhere classified

3.62

2.09

2.9

2.3

—

Other benign neoplasms of skin

589

1.38

2.08

1.9

2.0

—

Carcinoma in situ of skin, other sites/unspecified

5.04

2.07

1.2

1.5

—

Other abnormal findings in urine

5.03

2.07

1.8

2.4

—

Other and unspecified erythematous conditions

2.92

2.07

1.6

1.9

—

Agoraphobia

2.91

2.07

2.1

1.9

—

5.02

2.07

2.0

—

Hypertrophy of breast in women and men

292

1.54

2.07

1.9

2.1

—

Other secondary coxarthrosis

2.72

2.07

1.6

1.9

—

Acute pharyngitis

174

1.71

2.06

2.6

2.3

—

Other congenital malformations of tongue, mouth and pharynx

5.01

2.06

1.2

3.6

—

Other symptoms and signs involving the circulatory and respiratory systems

2.08

2.06

2.2

—

Psoriatic arthropathies

146

1.79

2.06

1.4

2.0

—

conjunctival degenerations and deposits

3.52

2.06

3.3

1.7

—

Other and unspecified myopathies

103

1.95

2.05

1.4

2.1

—

Male infertility

2.33

2.05

3.3

2.3

—

Chronic gastritis

382

1.47

2.04

2.1

1.9

—

Other and unspecified trigeminal disorders

4.03

2.04

1.5

2.2

—

Maxillary retrognathism

4.02

2.04

1.7

2.5

—

All dysplastic lesions of the cervix uteri

379

1.47

2.04

2.4

2.0

—

Ankyloglossia

4.01

2.03

2.2

3.0

—

Impetigo

2.41

2.02

2.6

2.1

—

Benign neoplasm of other and ill-defined parts of digestive system

262

1.57

2.02

1.8

1.9

—

Abnormalities of gait and mobility

147

1.77

2.02

1.7

2.0

—

Congenital malformations of heart and great arteries

186

1.67

2.02

2.2

—

Other otitis externa (chronic)

2.05

2.01

1.8

2.1

—

Dizziness and giddiness

170

1086

1.24

2.00

2.0

—

Other specified disorders of kidney and ureter

2.83

2.00

2.1

1.8

—

Post-traumatic stress disorder

104

1.93

2.00

1.8

2.3

—

Sleep disorders (combined)

269

1184

1.19

2.00

2.0

—

Hypertensive heart and/or renal disease

266

1.49

1.99

1.7

2.0

—

Other inflammation of eyelid

186

1.67

1.97

1.5

2.1

—

Ulcer of vagina/vulva

3.35

1.96

1.6

2.0

—

Chronic viral hepatitis

2.09

1.96

5.3

2.2

—

Hernia

214

1184

1.21

1.96

2.2

2.0

—

Other and unspecified disorders of vitreous body

672

1.34

1.95

2.0

—

Dysplasia of cervi uteri

277

1.47

1.95

2.4

2.1

—

Carcinoma in situ of skin of ear and external auricular canal

4.58

1.94

1.2

1.6

—

Hypotension

202

1.64

1.94

1.3

1.9

—

Other specified/unspecified inflammatory spondylopathies

2.20

1.94

1.0

2.0

—

Congenital malformations of the urinary system

2.19

1.94

2.4

—

Impacted teeth

256

1.53

1.94

2.4

2.1

—

Renal cell carcinoma of kidney

4.56

1.94

1.4

1.5

—

Vascular syndromes of brain in cerebrovascular disorders

2.57

1.94

3.3

1.6

—

Arthropathic psoriasis

164

1.71

1.94

1.4

2.1

—

Infective dermatitis

149

1.75

1.94

2.5

2.1

—

Other abnormal immunological findings in serum

3.77

1.93

1.3

2.3

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.77

1.93

4.7

2.9

—

3.77

1.93

1.0

1.6

—

Gonococcal infection

2.46

1.93

1.9

2.0

—

Fall on same level

274

1262

1.19

1.93

1.8

2.1

—

Malignant neoplasm of pancreas

2.73

1.93

2.2

2.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

471

1.40

1.92

2.2

2.0

—

Insulin, intermediate and long-acting

120

910

1.28

1.91

2.3

2.0

—

Statin medication

121

870

0.78

1.91

2.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

258

1.54

1.91

1.9

2.2

—

Congenital malformations of cardiac septa

2.11

1.89

2.1

2.2

—

Mixed specific developmental disorders

3.71

1.89

3.5

3.3

—

Tonsillectomy and adenotomy

132

723

1.27

1.89

2.3

2.1

—

Anomalies of dental arch relationship, including avohilmo

276

1.50

1.89

1.9

2.1

—

Disorders of muscles

143

1.75

1.88

1.5

2.3

—

Pemphigoid

3.20

1.88

1.6

—

Hypertensive Heart Disease

252

1.49

1.87

1.7

2.0

—

Disorders of eyelid in diseases classified elsewhere

2.66

1.86

1.9

—

Other disorders of binocular movement

2.87

1.86

2.9

2.0

—

Non-small cell lung cancer, squamous, helper endpoint

2.65

1.86

1.2

2.4

—

Vascular diseases of the intestine

2.66

1.86

1.0

1.5

—

Falls/tendency to fall

263

1110

1.19

1.86

1.9

2.1

—

COPD

560

1.33

1.86

1.5

2.0

—

Alzheimer’s disease (Late onset)

201

0.46

1.86

3.7

1.7

—

Type 2 diabetes, definitions combined

218

1064

1.20

1.84

1.8

2.0

—

Deficiency of other B group vitamins

3.55

1.84

1.8

2.1

—

Intussusception

3.55

1.84

1.5

1.6

—

Congenital malformations of the nervous system

3.55

1.84

4.0

2.6

—

Sciatica+with lumbago

113

810

1.28

1.83

2.1

2.0

—

Other diseases of intestine

198

1.62

1.82

1.6

1.9

—

Acute epiglottitis

4.19

1.82

2.8

1.8

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

4.19

1.82

3.4

1.5

—

Speech and linguistic disorders, excluding more controls

1.98

1.82

2.5

2.0

—

Congenital malformations of the urinary system

2.13

1.82

2.4

—

STROKE

125

668

1.27

1.81

2.0

2.1

—

Heterophoria

108

1.86

1.81

2.8

2.1

—

Disorders of tooth development and eruption

172

1.60

1.81

2.4

1.8

—

Acute peritonitis

2.06

1.80

2.7

1.9

—

Viral conjunctivitis

3.06

1.80

2.3

2.1

—

Melanocytic naevi of upper limb, including shoulder

3.06

1.80

1.4

2.4

—

Other bullous disorders

3.06

1.80

1.0

1.5

—

Other obstructive and reflux uropathy

2.58

1.80

2.8

1.8

—

Iron deficiency

2.77

1.79

2.5

2.4

—

HSIL lesion of the cervix uteri, vagina or vulva

295

1.49

1.79

2.1

2.0

—

Hyperplasia of prostate

325

1.36

1.78

2.4

2.0

—

Functional dyspepsia

403

1.42

1.77

1.8

2.1

—

Urticaria

479

1.38

1.76

1.9

2.1

—

Other and unspecified urticaria

296

1.49

1.76

1.9

2.2

—

Hordeolum and other deep inflammation of eyelid

2.10

1.76

2.1

1.9

—

Diseases of appendix

174

1291

1.22

1.75

1.8

2.0

—

Benign paroxysmal vertigo

446

1.39

1.75

2.0

—

Atypical facial pain

2.03

1.75

1.8

1.9

—

Perioral dermatitis

3.35

1.75

1.3

2.1

—

Coxarthrosis, primary, with hip surgery

674

1.31

1.75

1.9

—

D07AA Corticosteroids, weak (group I)

224

1.56

1.74

2.5

2.1

—

Degeneration of macula and posterior pole

558

1.31

1.74

1.9

2.0

—

Total colectomy

2.23

1.74

1.3

1.9

—

Total colectomy operation

2.23

1.74

1.2

1.9

—

Lack of expected normal physiological development

3.99

1.73

4.2

1.5

—

Retinoschisis and retinal cysts

2.93

1.72

1.4

1.5

—

Dilated cardiomyopathy

155

1.68

1.72

1.6

2.2

—

HSIL lesion of the vulva

3.87

1.72

1.8

2.2

—

Carcinoma in situ of other and unspecified genital organs

3.87

1.72

1.4

1.5

—

Hepatocellular carcinoma, including Hilmo

3.86

1.71

1.2

3.2

—

Redundant prepuce, phimosis and paraphimosis

303

1.47

1.71

1.7

2.1

—

Other congenital malformations of the digestive system

2.21

1.71

1.8

2.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

630

1.32

1.70

2.3

2.0

—

Substance use, excluding alcohol

315

1.46

1.70

2.5

2.1

—

Injuries to the head

258

1351

1.17

1.70

2.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

218

1.56

1.70

1.7

2.1

—

Pure hypercholesterolaemia

152

805

1.23

1.69

1.9

2.0

—

Inflammatory diseases of prostate (prostatitis)

179

1.62

1.69

2.2

2.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

444

1.38

1.68

2.5

2.1

—

Intracranial injury

127

963

1.25

1.66

2.0

2.1

—

Malignant neoplasm of testis, including Hilmo

3.17

1.66

3.2

1.7

—

Other and unspecified rosacea

119

1.77

1.66

2.0

1.9

—

Perforation of tympanic membrane

134

1.72

1.65

1.9

2.1

—

Alcohol dependence

442

0.63

1.65

3.0

2.0

—

HSIL lesion of the cervix uteri

268

1.49

1.65

2.1

2.0

—

Tooth eruption problems

191

1.58

1.64

2.3

2.1

—

Idiopathic gout

112

1.79

1.64

1.6

2.2

—

Retinal detachments and breaks

529

1.34

1.63

1.9

—

Disorders of synovium and tendon

117

815

1.26

1.63

2.4

2.0

—

Superficial injury of lower leg

393

1.40

1.63

1.7

2.1

—

Congenital malformations of the circulatory system

206

1.56

1.62

2.5

2.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

410

1.32

1.62

2.2

1.9

—

Smoking dependency

135

1.71

1.62

2.3

2.0

—

Appendicitis, broad definition

171

1283

1.21

1.62

1.8

2.0

—

Rheumatic valve diseases

3.58

1.61

1.4

—

Coronary atherosclerosis

135

688

1.24

1.61

1.9

2.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

2.15

1.61

2.2

1.8

—

Chronic diseases of tonsils and adenoids

183

962

1.20

1.61

2.2

2.0

—

Other congenital malformations of tongue, mouth and pharynx

3.57

1.61

1.2

2.9

—

Nail disorders

113

1.77

1.60

1.9

—

Hyperprolactinaemia

2.51

1.59

1.5

2.1

—

Pustular psoriasis

2.07

1.59

1.6

2.0

—

Mental and behavioural disorders due to alcohol

914

0.76

1.59

2.6

2.0

—

Other secondary gonarthrosis

1.95

1.59

1.8

1.9

—

Hypermetropia

1.91

1.59

2.5

2.1

—

Gonococcal infection

2.34

1.59

1.8

2.0

—

Mental and behavioural disorders due to tobacco

136

1.70

1.58

2.3

2.0

—

Open wound of shoulder and upper arm

3.01

1.58

1.3

2.6

—

Type 2 diabetes, strict (exclude DM1)

217

1077

1.18

1.58

1.8

2.0

—

Primary coxarthrosis, bilateral

430

1.37

1.57

1.9

—

Unspecified urinary incontinence

114

1.76

1.56

2.0

1.8

—

Sulfonylureas

424

0.68

1.56

1.8

—

Other congenital malformations

114

1.76

1.55

2.9

2.2

—

Injury of muscle and tendon at shoulder and upper arm level

613

0.70

1.55

1.5

1.9

—

Atopic dermatitis, strict definition

481

1.35

1.54

2.8

2.0

—

Other diseases of pancreas

107

1.78

1.54

1.5

2.2

—

L02BX Other hormone antagonists and related agents

2.04

1.54

1.5

2.3

—

Spasmodic torticollis

2.43

1.54

1.8

—

Embedded and impacted teeth

348

1.38

1.53

2.2

2.1

—

Injuries to the hip and thigh

658

1.28

1.53

2.6

1.9

—

Background retinopathy and retinal vascular changes

3.35

1.52

1.6

1.5

—

Adenocarcinoma and ductal carcinoma of pancreas

3.34

1.52

2.0

3.1

—

Malignant neoplasm of oesophagus, including Hilmo

3.34

1.52

1.2

3.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

435

1.36

1.51

2.4

2.1

—

Biological medicines for asthma

2.87

1.51

1.2

2.3

—

Other specific arthropathies, wide

2.87

1.50

1.0

1.6

—

Patent foramen ovale

2.87

1.50

2.5

2.6

—

Periodontal disease, other/unspecified

2.87

1.50

3.7

2.0

—

Cardiac murmurs and other cardiac sounds

114

1.74

1.50

2.4

2.2

—

Septal defects

1.96

1.50

2.0

2.2

—

Pustulosis palmaris et plantaris

2.16

1.50

1.7

2.0

—

Injuries to the thorax

747

1.27

1.50

2.1

2.0

—

Ventricular septal defect, a heart condition

2.86

1.50

2.8

2.6

—

Hypertrophy of breast

250

1.48

1.49

1.6

2.2

—

Failed induction of labour

1.90

1.49

2.9

2.4

—

Conductive hearing loss, unspecified

116

1.73

1.48

1.9

2.1

—

Type 2 diabetes, definitions combined, including avohilmo

217

1076

1.17

1.47

1.9

2.0

—

Hypogonadotropic hypogonadism

2.23

1.46

2.0

1.8

—

Other female pelvic inflammatory diseases

243

1.48

1.46

1.5

2.2

—

Maternal care for cervical incompetence

2.23

1.46

1.4

1.8

—

Other disorders of pigmentation

2.23

1.46

1.8

1.9

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

235

1.49

1.46

1.7

2.3

—

Presence of other devices

308

1.42

1.46

1.5

2.0

—

Occupational exposure to risk-factors

2.38

1.45

2.9

1.9

—

Gonarthrosis [arthrosis of knee](FG)

146

698

1.22

1.45

1.9

2.0

—

Mandibular retrognathia AND surgery (BSSO)

2.51

1.45

1.9

2.0

—

Benign neoplasm: Skin of lower limb, including hip

2.51

1.45

2.3

2.0

—

Unspecified/other endometriosis

117

1.71

1.44

1.5

1.9

—

Certolizumab pegol

3.14

1.44

1.2

2.3

—

Viral agents as the cause of diseases classified to other chapters

3.14

1.44

3.8

2.1

—

Dental pulpitis, including avohilmo

216

1198

1.17

1.43

2.0

—

Infliximab

2.74

1.43

1.2

2.1

—

Arterial embolism and thrombosis of lower extremity artery

2.73

1.43

1.3

—

Acute appendicitis

157

1226

1.20

1.42

1.8

2.0

—

Other headache syndromes

673

1.28

1.42

1.9

2.0

—

Thoracic aortic aneurysm

204

1.52

1.42

1.9

—

Paracetamol or NSAID medication

108

1.54

1.42

2.0

2.1

—

Abrasion of teeth

560

1.30

1.42

1.8

2.1

—

Acute appendicitis, no complications

125

1019

1.22

1.41

1.8

2.1

—

Other CVD

262

1.45

1.40

1.4

2.0

—

Peritonsillar abscess

329

1.40

2.0

2.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

544

1.31

1.39

1.9

2.1

—

Inflammatory disease of uterus

197

1.53

1.39

1.8

2.2

—

Mental retardation, excluding more controls

2.25

1.39

4.4

2.1

—

Parkinson's disease

199

0.50

1.39

2.0

1.9

—

Other and unspecified intracranial injuries

2.42

1.39

3.3

1.9

—

Social phobias

1.77

1.38

2.2

—

Tuberculosis

2.08

1.38

2.5

2.2

—

Fracture of lower leg, including ankle

117

944

1.23

1.38

2.0

2.1

—

Coxibs

251

1.34

1.38

2.5

1.9

—

Unknown and unspecified causes of morbidity

1.94

1.38

1.4

2.0

—

Selective serotonin reuptake inhibitors

228

1023

1.16

1.37

2.2

2.0

—

Delirium, not induced by alcohol and other psychoactive substances

142

1.62

1.37

1.7

1.8

—

Complications of other internal prosthetic devices, implants and grafts

2.20

1.37

3.1

1.6

—

Lesion of sciatic nerve

2.20

1.37

1.9

1.4

—

Autism spe, excluding more controls

2.62

1.37

2.3

2.0

—

Rheumatic fever incl heart disease

2.62

1.37

1.3

1.5

—

Delayed milestone in childhood

3.01

1.36

4.2

3.5

—

Spermatocele

104

1.73

1.36

1.9

2.1

—

Alzheimer disease, excluding more controls

157

0.54

1.36

3.4

1.8

—

Carbimazole or st.post thyroidectomy, condition for graves disease

336

0.62

1.36

1.5

2.1

—

Alcohol abuse, main dg

236

0.55

1.36

2.1

—

Parkinson's disease, including avohilmo

210

0.52

1.36

2.1

1.9

—

Bacterial, viral and other infectious agents

112

1.70

1.35

2.7

2.2

—

Other and unspecified mental retardation

2.94

1.35

5.0

2.7

—

Coxarthrosis, primary

117

809

1.22

1.34

1.8

1.9

—

Other chronic obstructive pulmonary disease

537

1.27

1.34

1.6

2.0

—

Chondrocostal junction syndrome [Tietze]

2.15

1.33

1.2

1.7

—

Hyperkinetic disorders, excluding more controls

137

1.61

1.33

1.4

2.2

—

Dystonia

1.92

1.33

1.6

1.8

—

Impacted maxillary molar

1.92

1.33

2.2

2.4

—

Visual impairment including blindness (binocular or monocular)

1.92

1.33

2.1

1.6

—

Fracture of lumbar spine and pelvis

315

1.40

1.33

2.8

2.1

—

Laparoscopic right hemicolectomy

1.97

1.32

3.0

1.7

—

Diseases of tongue

2.04

1.32

1.2

2.0

—

Alzheimer’s disease (Late onset), excluding more controls

129

0.51

1.32

4.0

1.7

—

Diseases of peritoneum

136

1.62

1.32

2.3

2.1

—

Unspecified fall

102

812

1.24

1.32

1.6

2.1

—

L02BA Anti-estrogens

246

0.57

1.32

1.8

1.9

—

Follicular cysts of skin and subcutaneous tissue

283

1.42

1.31

2.0

2.1

—

Dermatophytosis

129

1069

1.21

1.30

1.8

2.0

—

Oesophageal varices

2.10

1.30

1.8

1.9

—

Leisure time condition

267

1.43

1.29

2.1

2.2

—

Peripheral retinal degeneration

2.36

1.29

2.1

1.8

—

Alcohol use disorder, ICD-based

750

0.76

1.29

2.8

2.0

—

Pyogenic granuloma

2.79

1.28

1.0

1.9

—

Sequelae of injuries of head

1.89

1.28

1.7

2.2

—

Other disorders of the genitourinary system

177

1.53

1.28

2.6

1.8

—

Hallux valgus (acquired)

363

1.31

1.28

1.8

1.9

—

Congenital ovarian cysts

2.09

1.27

2.2

2.4

—

Artificial opening status

1.94

1.27

1.5

2.1

—

Urethral stricture

1.94

1.27

3.0

2.5

—

Monoarthritis, not elsewhere classified

2.01

1.27

2.2

2.0

—

Open bite

2.00

1.27

1.5

2.5

—

Hidradenitis suppurativa

2.05

1.27

1.0

2.3

—

Benign neoplasm of other and unspecified endocrine glands

202

1.49

1.26

3.1

2.1

—

Anogenital herpesviral [herpes simplex] infection

146

1.58

1.25

2.4

—

Psoriatic arthropathies, ICD10

162

1.55

1.25

1.4

2.0

—

Other specified/unspecified bacterial intestinal infections

1.82

1.25

2.7

1.8

—

Other disorders of eyelid

628

1.26

1.25

2.3

1.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1.74

1.25

1.7

1.9

—

Transport accidents

103

721

1.23

1.24

2.1

2.0

—

Pathological resorption of teeth

2.23

1.24

1.9

2.0

—

Other sexually transmitted chlamydial diseases

1.86

1.23

1.8

2.5

—

Melanoma in situ

2.01

1.23

1.9

1.5

—

Other condition

220

1.46

1.23

2.7

2.1

—

Disorders of continuity of bone

139

1.59

1.23

1.8

2.1

—

Injury of other and unspecified intrathoracic organs

1.77

1.23

2.1

2.4

—

Polyarthritis, unspecified

2.05

1.22

1.7

2.1

—

Other and unspecified iridocyclitis

2.05

1.22

1.4

1.9

—

Varicose veins

119

743

1.21

1.22

2.0

1.9

—

Malignant neoplasm of testis

2.64

1.22

2.2

1.7

—

Other localized connective tissue disorders

2.64

1.22

2.2

1.7

—

Chronic mastoiditis

2.64

1.21

1.4

1.9

—

Vasomotor and allergic rhinitis

598

1.26

1.21

2.0

2.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

806

0.78

1.21

2.7

2.0

—

Noninflammatory disorders of female genital tract

351

1.26

1.21

2.2

2.0

—

Other strabismus

329

1.36

1.21

2.9

2.2

—

Problems related to lifestyle

124

1.62

1.20

1.5

2.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

209

1091

1.15

1.20

2.0

—

Deep bite

136

1.55

1.20

2.3

2.1

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

132

1.59

1.20

1.9

2.1

—

Other psoriatic arthropathies

156

1.54

1.20

1.3

2.0

—

Nummular dermatitis

101

1.69

1.19

2.5

2.1

—

991

0.81

1.19

2.6

2.0

—

1024

0.82

1.19

2.5

2.0

—

IgA nephropathy (IgA glomerulonephritis)

2.32

1.19

1.5

2.2

—

Granulomatous disorders of skin and subcutaneous tissue

2.32

1.19

5.2

2.0

—

Dronedarone medication

2.31

1.19

1.8

2.3

—

Other specified/unspecified disorders of bone/cartilage

2.31

1.19

1.0

1.8

—

Autism spe

2.31

1.19

2.3

2.4

—

Autism

2.31

1.19

2.3

—

Problems related to social environment

2.31

1.18

3.2

2.0

—

Benign neoplasm: Long bones of lower limb

2.11

1.18

2.0

—

Migraine without aura and triptan purchases

247

1.42

1.18

1.6

2.0

—

Toxic effects of substances chiefly nonmedicinal as to source

168

0.53

1.18

3.7

2.2

—

Decubitus ulcer and pressure area

1.88

1.18

2.0

—

Fracture of rib(s), sternum and thoracic spine

471

1.30

1.18

2.1

2.0

—

Bacterial, viral and other infectious agents

117

1.63

1.18

2.7

2.2

—

Migraine

101

670

1.22

1.17

2.1

2.0

—

Other bursopathies

206

1.46

1.17

2.0

2.1

—

Pediculosis, acariasis and other infestations

1.78

1.17

1.6

1.9

—

Schizophrenia

261

0.61

1.16

2.2

2.1

—

Lesion of radial nerve

2.06

1.15

2.0

2.1

—

Viral conjunctivitis

2.06

1.15

2.4

1.8

—

Dissociative [conversion] disorders

2.06

1.15

1.4

1.9

—

Herpesviral keratitis and keratoconjunctivitis

2.06

1.15

2.6

2.1

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.51

1.15

2.2

2.0

—

Pedestrian injured in collision with pedal cycle

0.00

1.15

0.0

1.7

—

Melanocytic naevi of trunk

174

1.50

1.15

1.7

2.2

—

Speech and linguistic disorders

1.67

1.15

2.5

2.2

—

Acute pancreatitis

291

1.38

1.15

1.5

2.0

—

Overjet

2.49

1.14

2.6

3.3

—

Maternal care for other known or suspected fetal problems

231

1.34

1.14

2.2

2.1

—

Deviated nasal septum

579

1.26

1.14

1.5

2.0

—

Antenatal screening

188

0.66

1.13

1.8

2.0

—

Voice disturbances

431

1.30

1.12

2.0

2.1

—

Right hemicolectomy

1.90

1.12

1.7

1.6

—

Unstable angina pectoris

454

0.75

1.11

2.3

2.0

—

All dysplastic lesions of the vulva

1.97

1.11

1.9

2.0

—

Other shoulder lesions

143

1.54

1.11

1.5

2.2

—

Superficial injury of forearm

127

1.58

1.11

2.3

2.0

—

Lactose intolerance

2.26

1.10

1.1

1.9

—

Algoneurodystrophy

2.26

1.10

1.3

2.0

—

Postprocedural disorders of digestive system, not elsewhere classified

2.26

1.10

2.1

1.7

—

Tooth agenesis EXCLUDE clefts and syndromes

2.26

1.10

3.4

2.6

—

Meniscus derangement

113

633

1.20

1.10

2.1

—

Alcohol abuse, main dg, excluding more controls

220

0.59

1.10

2.1

—

Primary open-angle glaucoma

426

1.29

1.10

2.1

1.9

—

Fracture of femur

328

1.33

1.10

2.1

1.8

—

Presbycusis

142

1.54

1.10

1.7

1.8

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

595

1.22

1.09

2.3

2.0

—

Type 1 diabetes, definitions combined

137

0.51

1.09

2.3

2.4

—

Asthma and allergy, excluding more controls

118

1.59

1.09

1.8

2.1

—

Asthma and allergy

118

1.59

1.09

1.8

2.1

—

Type 1 diabetes, strict (exclude DM2)

138

0.51

1.09

2.3

—

Injury of muscle and tendon at lower leg level

243

1.40

1.09

1.6

2.1

—

Malignant neoplasm of ovary, including Hilmo

1.95

1.08

2.9

2.1

—

Corneal ulcer

269

1.38

1.08

1.8

2.1

—

Lichen planus

177

1.47

1.07

2.1

—

Autoimmune hyperthyroidism

1.87

1.07

1.7

2.1

—

Hemiplegia

1.93

1.06

2.5

1.8

—

Heartburn

137

1.54

1.05

1.7

2.2

—

Other sexually transmitted chlamydial diseases

129

1.55

1.05

1.8

2.3

—

Schizophrenia or delusion

534

0.75

1.05

2.1

—

Cardiodefibrillation

559

1.25

1.04

1.8

1.9

—

Mental retardation

1.99

1.04

4.4

2.3

—

Mixed conductive and sensorineural hearing loss

170

1.47

1.04

2.3

2.1

—

Prolonged pregnancy

200

0.61

1.03

1.3

2.1

—

Acute pancreatitis (for exclusion)

297

1.35

1.03

1.5

2.0

—

Aggressive periodontitis

2.28

1.03

2.6

1.5

—

Urethritis and urethral syndrome

2.28

1.03

1.0

1.9

—

Dementia in Alzheimer disease

151

0.56

1.03

4.1

1.6

—

Emotional disorders starting during childhood or adolecense, excluding more controls

1.95

1.03

2.8

2.3

—

Emotional disorders starting during childhood or adolescence

1.94

1.03

2.8

2.3

—

Erosion of teeth , including avohilmo

402

1.29

1.02

2.3

2.1

—

Other orthopaedic follow-up care

1.84

1.02

1.3

2.3

—

Trigeminal neuralgia

1.74

1.02

2.1

1.7

—

Specific development disorders of scholastic skills

1.93

1.02

2.7

2.6

—

Other disorders of glucose regulation and pancreatic internal secretion

106

1.61

1.02

3.7

2.3

—

Atopic dermatitis

115

794

1.19

1.02

2.4

2.0

—

LeFortI or BSSO operation

1.92

1.02

1.8

2.0

—

Other disorders starting during childhood or adolecense, excluding more controls

1.92

1.02

3.0

2.5

—

Other/unspecified reactive arthropathies

1.69

1.01

1.8

2.1

—

Congenital malformations and deformations of the musculoskeletal system

114

1.57

1.00

2.2

2.3

—

Cholecystitis

180

1.45

1.00

2.0

—

Paralytic ileus

2.00

1.00

1.6

1.9

—

Traumatic subdural haemorrhage

141

1.50

1.00

1.5

1.9

—

Mental retardation, wide definition

1.87

1.00

4.4

2.3

—

Chronic periodontitis, complicated

116

974

1.18

0.99

2.5

1.9

—

Migraine without aura

282

1.35

0.99

1.6

1.9

—

Parkinson's disease, strict definition

176

0.57

0.99

2.0

1.9

—

Other and unspecified vascular occlusions

115

1.57

0.99

2.2

2.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

283

1.33

0.98

1.7

2.0

—

Traumatic amputation of wrist and hand

1.84

0.98

1.7

2.2

—

Generalized epilepsy

1.84

0.98

4.3

2.3

—

Viral agents as the cause of diseases classified to other chapters

2.18

0.98

3.8

2.2

—

Other arthrosis

104

603

1.19

0.98

1.8

2.1

—

Primary open-angle glaucoma, strict

369

1.30

0.98

1.9

—

Open wound of wrist and hand

792

1.20

0.98

2.0

2.1

—

Benign neoplasm: Descending colon

1.67

0.97

2.1

—

Disturbance of activity and attention

153

1.47

0.97

1.4

2.3

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.97

0.0

1.5

—

Manic episode

1.95

0.97

1.4

1.9

—

Cluster headache, strict

1.95

0.97

1.4

1.9

—

Diabetes, insulin treatment (Kela reimbursement)

219

1172

1.13

0.97

2.0

—

Haemorrhoids and perianal venous thrombosis

476

1.26

0.96

2.3

1.9

—

Mucosal proctocolitis

190

1.42

0.96

1.6

2.1

—

Tinnitus

371

1.30

0.96

2.0

—

Other keratitis

165

1.46

0.96

2.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

513

1.25

0.96

1.5

2.1

—

Superficial injury of hip and thigh

190

1.42

0.96

3.2

1.8

—

Diabetes medication

228

1203

1.12

0.94

1.9

2.0

—

Hypoglycaemia, other or unspecified

1.65

0.94

4.1

2.1

—

Hepatic failure, not elsewhere classified

1.90

0.94

1.4

1.9

—

Follow-up care involving plastic surgery

1.90

0.94

1.3

2.1

—

Lichen planus, including avohilmo

294

1.33

0.94

2.2

1.9

—

Other and unspecified injuries of shoulder and upper arm

2.23

0.93

5.5

1.9

—

conjunctival haemorrhage

101

1.59

0.93

1.9

2.0

—

Spinal stenosis

101

645

1.19

0.93

1.7

1.9

—

Examination and observation for other reasons

104

506

1.19

0.92

2.0

1.9

—

Alcohol use disorder, Swedish definition

934

0.83

0.92

2.6

2.0

—

Gestational diabetes (for exclusion)

411

0.78

0.91

2.0

2.1

—

Diabetes mellitus in pregnancy

328

0.76

0.91

2.0

2.1

—

Presence of cardiac and vascular implants and grafts

463

1.22

0.91

1.5

2.0

—

Presbyopia

1.60

0.90

1.9

2.0

—

Excessive attrition of teeth

117

1003

1.17

0.90

2.1

2.0

—

Haemorrhage in early pregnancy

443

1.25

0.90

2.1

—

Major anomalies of jaw size

2.07

0.89

2.2

2.3

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.07

0.89

1.0

1.9

—

Ectropion of eyelid

2.07

0.89

1.3

1.6

—

Graves disease, strict definition

153

0.59

0.88

1.4

1.9

—

Scabies

1.79

0.87

1.5

2.0

—

Other aneurysm

1.79

0.87

2.3

2.2

—

Intestinal adhesions without obstruction

103

1.56

0.87

1.4

2.0

—

Benign neoplasm: Conjunctiva

2.00

0.87

1.7

2.0

—

Chronic laryngitis and laryngotracheitis

203

1.38

0.87

1.9

2.1

—

Oesophagitis

1.72

0.86

1.3

2.3

—

Infective bursitis

1.82

0.86

1.6

2.0

—

Other vitreous opacities

1.82

0.86

1.4

1.6

—

Fracture of foot, except ankle

396

1.26

0.86

2.1

—

Unspecified jaundice

1.82

0.86

2.6

2.4

—

Lateral epicondylitis

204

0.64

0.85

1.2

2.2

—

Stenosis and insufficiency of lacrimal passages

120

1.50

0.85

2.1

2.0

—

Schizophrenia, schizotypal and delusional disorders

537

0.78

0.85

2.0

2.1

—

Ventral hernia

370

1.27

0.85

2.3

1.9

—

Ulcer of oesophagus

1.63

0.84

1.2

2.4

—

LSIL lesion of the vulva

1.94

0.84

1.8

2.3

—

Right bundle-branch block

1.94

0.84

1.2

2.3

—

Respiratory tuberculosis, not confirmed

1.94

0.84

1.8

1.5

—

Chronic tubulo-interstitial nephritis

1.94

0.84

1.3

1.7

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

256

1.33

0.84

2.2

2.1

—

Malignant neoplasm of rectum, including Hilmo

1.63

0.84

1.5

2.3

—

Other menopausal disorders

266

0.76

0.84

2.5

2.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1.76

0.83

2.8

2.4

—

Multiple delivery

111

0.54

0.83

2.5

2.1

—

Type 1 diabetes, strict definition

113

0.53

0.83

2.5

2.4

—

Appendectomy

137

1145

1.14

0.82

1.9

2.1

—

Other/unspecified synovitis and tenosynovitis

171

1.41

0.82

3.6

2.2

—

Extreme obesity with alveolar hypoventilation

1.74

0.82

1.9

1.7

—

Haemangioma, any site

121

1.49

0.82

2.1

2.0

—

Carcinoma in situ of cervix uteri

121

1.49

0.82

2.1

2.2

—

Embedded teeth, including avohilmo

121

1.49

0.82

1.7

2.2

—

Sequelae of injuries of lower limb

141

0.57

0.82

1.3

2.0

—

Recurrent dislocation of patella

1.70

0.82

1.4

2.3

—

Superficial injury of abdomen, lower back and pelvis

214

1.36

0.82

2.0

2.1

—

Carcinoma in situ, bladder

1.88

0.82

1.5

2.0

—

Motorcycle rider injured in other and unspecified transport accidents

1.65

0.81

2.5

2.0

—

Superficial injury of shoulder and upper arm

165

0.61

0.81

1.4

2.2

—

Degenerative macular diseases

155

1.42

0.81

1.6

2.0

—

Femoral hernia

1.71

0.80

2.1

1.6

—

Haemangioma and lymphangioma, any site

130

1.46

0.80

2.0

2.1

—

Glaucoma

104

768

1.17

0.80

2.0

1.9

—

Abscess of anal and rectal regions

122

1.48

0.80

1.4

2.2

—

Enthesopathies of lower limb, excluding foot

347

1.27

0.79

1.7

2.0

—

Benign neoplasm of other and unspecified sites

1.82

0.79

1.3

1.6

—

Procedures for purposes other than remedying health state

0.00

0.79

0.0

2.1

—

Perineal laceration during delivery

216

1.32

0.79

2.2

2.1

—

Other and unspecified injuries of lower leg

106

1.51

0.78

2.2

—

Respiratory tuberculosis

1.67

0.78

2.1

1.8

—

Respiratory tuberculosis, confirmed and not-confirmed

1.67

0.78

2.1

1.8

—

Assault

190

1.37

0.78

1.9

2.1

—

Calcific aortic valvular stenosis, operated

389

1.25

0.78

2.1

1.8

—

Calcific aortic valvular stenosis

389

1.25

0.78

2.1

1.8

—

Female infertility, associated with anovulation

1.53

0.78

1.8

2.1

—

Reactive arthropathies

131

1.45

0.78

1.8

2.1

—

Lichen simplex chronicus and prurigo

1.62

0.78

2.2

1.8

—

Congenital malformations of eye, ear, face and neck

1.62

0.78

2.3

—

Complications of labour and delivery

120

578

1.15

0.78

2.3

2.0

—

Wide developmental disorders, excluding more controls

1.79

0.77

2.3

—

Other intracranial haemorrhages

0.00

0.77

0.0

1.4

—

Parkinson's disease, excluding more controls

153

0.62

0.77

2.0

1.8

—

Acetic acid derivatives and related substances

244

1.23

0.76

2.1

1.9

—

Pruritus

140

1.43

0.76

2.4

1.9

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

217

1.34

0.76

1.6

2.0

—

Short Achilles tendon (acquired)

1.77

0.76

3.5

1.9

—

Other and unspecified mononeuropathies of upper limb

1.77

0.76

1.7

1.8

—

Carcinoma in situ of other and unspecified sites

1.77

0.76

1.5

1.9

—

Wide developmental disorders

1.76

0.76

2.3

2.6

—

Menorrhagia

307

1.21

0.75

2.0

—

Arterial embolism and thrombosis

1.70

0.75

1.2

2.2

—

Leiomyoma of uterus

115

565

1.15

0.75

1.9

2.0

—

Other hearing loss

369

1.25

0.74

1.9

—

Loose body in joint

2.09

0.74

1.6

1.8

—

Keratoconus

2.09

0.74

2.0

—

Abnormal blood-pressure reading, without diagnosis

1.67

0.74

2.1

1.9

—

Polycystic ovarian syndrome

1.67

0.74

2.2

2.3

—

Postpartum hemorraghe, parous women as controls

313

1.25

0.74

1.9

2.1

—

Benign neoplasm: Skin of other and unspecified parts of face

141

1.42

0.74

2.1

2.2

—

Diabetic maculopathy, excluding more controls

158

1.39

0.74

2.0

2.4

—

Restless leg syndrome

201

1.34

0.74

1.6

2.0

—

Follow-up examination after treatment for malignant neoplasms

116

1.47

0.74

1.8

1.9

—

Abnormal serum enzyme levels

469

0.79

0.74

2.0

—

Muscle strain

1.85

0.73

2.1

2.5

—

Other benign neoplasms of uterus

1.64

0.73

1.3

1.4

—

Volvulus

2.00

0.72

2.2

1.6

—

Reactive arthropathies, FINNGEN

100

1.50

0.72

1.9

2.1

—

Acne vulgaris

100

1.50

0.72

2.7

2.2

—

Diffuse brain injury

1.80

0.72

2.1

2.4

—

Disorders of orbit

1.61

0.72

1.2

1.6

—

Memory loss

108

0.55

0.72

2.5

1.9

—

Family history of certain disabilities and chronic diseases leading to disablement

1.67

0.72

1.6

2.1

—

Left ventricular outflow tract obstruction, narrow definition

1.67

0.72

1.5

2.4

—

Divergent concomitant strabismus

110

0.54

0.72

2.3

2.0

—

Radiculopathy

246

1.30

0.71

1.6

1.9

—

Amputation of toe

1.58

0.71

1.3

2.0

—

Systemic atrophies primarily affecting the central nervous system

1.75

0.71

1.3

1.9

—

Cluster headache, wide

1.75

0.71

1.4

1.8

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

134

1.42

0.71

3.1

2.1

—

Tobacco use

1.58

0.71

1.2

1.9

—

Specific development disorders of speech and language

1.58

0.71

2.1

2.3

—

Burn and corrosion confined to eye and adnexa

1.93

0.70

1.8

1.9

—

Unspecified event, undetermined intent

1.93

0.70

2.6

2.2

—

Pediculosis, acariasis and other infestations

247

1.30

0.70

1.7

2.2

—

Glaucoma suspect

554

1.19

0.70

2.3

2.0

—

Hyperkinetic disorders

165

1.37

0.70

1.4

2.4

—

Bilateral sagittal split ramus osteotomy operation

1.71

0.70

1.9

2.0

—

Bicuspidal aortic valve syndrome

1.71

0.70

1.3

2.4

—

Atrial septal defect

1.70

0.69

2.7

2.5

—

Mouth breathing

692

1.17

0.69

1.8

2.1

—

Ischaemic heart disease, wide definition

161

891

1.12

0.69

1.7

2.1

—

Valvular operations

169

1.36

0.69

1.6

1.9

—

Other disorders starting during childhood or adolescence

1.54

0.69

3.0

2.8

—

Oral lichen planus

1.86

0.68

1.6

1.4

—

Benign neoplasm: Larynx

1.86

0.68

2.4

2.3

—

Maltreatment syndromes

1.64

0.68

2.0

2.2

—

Benign neoplasm: Rectosigmoid junction

1.67

0.68

2.0

1.8

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.60

0.68

2.1

2.2

—

Other appendicitis

127

1.42

0.67

2.1

2.0

—

119

0.59

0.67

1.6

2.4

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

338

1.24

0.67

2.2

1.9

—

Operations 2 for CAVS

389

1.22

0.67

2.2

1.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

389

1.22

0.67

2.2

1.8

—

Alcohol withdrawal state with delirium

0.54

0.67

3.2

2.0

—

Dementia in other diseases classified elsewhere

1.63

0.67

1.9

2.2

—

Calcific aortic valvular stenosis, including rheumatic fever

389

1.22

0.66

2.2

1.8

—

Benign neoplasm: Colon

104

869

1.14

0.66

2.1

1.9

—

All dysplastic lesions of the vagina

1.79

0.66

1.6

1.9

—

Femoral hernia, unilateral

1.79

0.66

2.8

1.4

—

Inguinal hernia, unilateral

1.79

0.66

2.8

1.4

—

Inguinal of femoral hernia, unilateral

1.79

0.66

2.8

1.4

—

Chalazion

162

1.36

0.66

2.3

2.0

—

Vestibular neuronitis

128

1.41

0.65

1.7

2.1

—

Car occupant injured in noncollision transport accident

1.59

0.65

2.6

2.0

—

Cyst of Bartholin Gland

1.59

0.65

1.9

2.3

—

Female infertility, tubal origin

1.57

0.65

1.4

1.8

—

Embolic stroke

1.59

0.65

2.3

2.0

—

Hallux rigidus

190

0.68

0.65

2.4

2.0

—

Foreign body entering into or through eye or natural orifice

103

1.46

0.65

1.5

2.1

—

Retinal vascular occlusion

154

1.37

0.64

2.0

1.9

—

Retinal vascular disorders

154

1.36

0.64

2.0

1.9

—

Parkinson's disease, strict definition, excluding more controls

147

0.65

0.64

2.0

1.7

—

Shoulder lesions

158

859

1.11

0.64

1.8

2.0

—

Benign neoplasm of bone and articular cartilage

120

1.42

0.64

2.0

2.1

—

Crossbite

1.50

0.64

2.4

2.3

—

Use of disulfiram, acamprosate or naltrexone

128

0.62

0.64

2.5

2.1

—

Abnormalities of forces of labour

129

0.62

0.63

2.1

—

Atrial septal defect, secundum type

1.72

0.63

3.0

2.6

—

Benign neoplasm of major salivary glands

129

1.40

0.63

2.2

2.1

—

Diabetic retinopathy, strict definition

214

1.28

0.62

1.5

2.0

—

LSIL lesion of the cervix uteri

164

1.34

0.62

2.7

2.1

—

Type 1 diabetes, strict definition, subgroup 1

102

0.59

0.62

2.5

2.3

—

Tuberculosis, IBD comorbidity

1.55

0.62

2.5

1.9

—

Non-allergic asthma

121

1.41

0.62

1.9

2.0

—

Abdominal aortic aneurysm (AAA)

1.46

0.61

1.8

1.9

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

1.55

0.61

2.6

1.7

—

Other and unspecified nonorganic psychotic disorders

313

0.77

0.61

1.8

2.1

—

Benign neoplasm: Skin of ear and external auricular canal

1.67

0.61

1.4

1.5

—

Mental and behavioural disorders due to opioids

1.60

0.61

3.0

2.3

—

Examination and encounter for administrative purposes

1.60

0.61

2.5

2.3

—

Benign neoplasm: Stomach

130

1.39

0.61

1.8

2.0

—

Postpartum hemorraghe, all women as controls

373

1.21

0.61

1.9

2.1

—

Ulcerative rectosigmoiditis

113

1.42

0.61

1.5

2.3

—

Cerebrovascular diseases

148

935

1.11

0.61

2.1

2.0

—

Disorders of breast

705

1.15

0.60

1.8

2.0

—

Acne

130

1.38

0.60

2.8

2.2

—

Olecranon bursitis

1.48

0.60

1.5

2.4

—

Venous complications and haemorrhoids in pregnancy

0.00

0.60

0.0

2.1

—

Injury of urinary and pelvic organs

0.00

0.60

0.0

1.8

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

0.60

0.0

1.8

—

Impingement syndrome of shoulder

401

0.80

0.60

1.6

2.0

—

0.00

0.60

0.0

3.4

—

Benign neoplasm of colon, rectum, anus and anal canal

123

952

1.12

0.60

2.0

—

Bitten or struck by other mammals

165

1.33

0.60

1.7

2.1

—

Toxic effect of alcohol

0.00

0.60

0.0

1.6

—

Open wound of head

110

940

1.13

0.60

2.0

2.1

—

Artificial joint operation, meniscal resection

189

1118

1.10

0.59

1.8

2.0

—

COPD, hospital admissions

610

1.15

0.59

1.6

1.9

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

109

773

1.13

0.59

2.1

1.9

—

Tuberculosis, wide

1.53

0.59

2.5

2.1

—

Postpartum haemorrhage

320

1.21

0.59

1.9

2.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

282

1.23

0.58

2.1

2.2

—

Separation of retinal layers (serosa)

1.57

0.58

3.0

2.2

—

0.00

0.58

0.0

3.4

—

Habitual aborter

0.00

0.58

0.0

2.0

—

Benign neoplasm of meninges

140

1.36

0.58

1.6

2.1

—

Other local infections of skin and subcutaneous tissue

140

1.36

0.58

1.9

2.2

—

Certain conditions originating in the perinatal period

1.45

0.58

4.3

2.2

—

Nonalcoholic fatty liver disease

149

1.34

0.57

1.5

2.0

—

Other extrapyramidal and movement disorders in other diseases

364

1.21

0.57

2.0

—

Congenital malformations of aortic and mitral valves

1.48

0.57

1.4

2.5

—

Postmenopausal bleeding

237

0.81

0.56

1.6

2.0

—

Injury of eye and orbit

220

1.27

0.56

1.7

2.2

—

Superficial injury of thorax

220

1.27

0.56

2.2

—

Dislocation, sprain and strain of joints and ligaments at neck level

229

1.27

0.56

1.9

2.0

—

Diabetic retinopathy, excluding more controls

213

1.21

0.56

1.6

2.0

—

Other and unspecified glaucoma

1.51

0.56

1.5

1.6

—

Labour and delivery complicated by fetal stress [distress]

239

0.79

0.56

2.0

2.1

—

Palmar fascial fibromatosis [Dupuytren]

229

0.74

0.55

1.4

1.9

—

Vitamin B12 deficiency anaemia

124

1.37

0.55

2.3

2.2

—

Personal history of other diseases and conditions

141

1.34

0.55

2.1

—

Benign lipomatous neoplasm

477

1.17

0.54

1.6

2.0

—

Excessive earwax

104

904

1.12

0.54

1.9

2.0

—

Lichen simplex chronicus

1.58

0.54

1.8

1.9

—

Sudden idiopathic hearing loss

142

1.34

0.54

1.9

—

Endometriosis of pelvic peritoneum

237

1.25

0.53

1.5

2.1

—

Barrett oesophagus

1.48

0.53

1.3

2.4

—

Malignant neoplasm of rectum

1.48

0.53

1.7

2.3

—

Salpingitis and oophoritis

258

1.24

0.53

1.4

2.2

—

Dermatitis due to ingested food

1.56

0.53

2.8

2.3

—

Benign neoplasm of mouth and pharynx

160

1.31

0.53

1.9

2.0

—

Disorders of speech understanding and production

1.55

0.53

1.3

2.4

—

Ulcerative proctitis

1.49

0.53

1.5

2.3

—

Effects of other external causes

1.54

0.53

2.2

2.1

—

Subacute thyroiditis

1.54

0.53

1.5

2.1

—

Benign neoplasm: Parotid gland

108

1.39

0.53

2.0

2.1

—

COPD, early/later onset

615

1.14

0.52

1.6

1.9

—

Postmenopausal atrophic vaginitis

247

1.18

0.52

2.0

—

Injuries to the shoulder and upper arm

150

1325

0.91

0.52

1.9

2.0

—

Schizophrenia or delusion, excluding more controls

475

0.83

0.52

2.1

2.0

—

Pilonidal cyst

117

1.37

0.52

1.7

2.2

—

Organic, including symptomatic, mental disorders

579

0.87

0.52

2.2

1.9

—

Congenital malformations of genital organs

125

1.35

0.52

2.4

2.2

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.50

0.51

1.3

1.8

—

Infections of breast associated with childbirth

1.50

0.51

2.3

2.2

—

Hypertrophic scar

1.41

0.51

1.3

2.2

—

Other spirochaetal diseases

508

1.16

0.51

1.9

2.0

—

Other spirochaetal diseases

499

1.16

0.51

1.9

2.0

—

Dislocation, sprain and strain of joints and ligaments of knee

124

1033

1.11

0.51

1.7

2.1

—

Fall on same level involving ice and snow

110

989

1.11

0.50

2.1

2.0

—

Plantar fascial fibromatosis

145

0.69

0.50

1.8

2.2

—

Use of levodopa decarboxylase inhibitor

168

0.71

0.50

2.1

2.0

—

L02BG Aromatase inhibitors

434

1.17

0.50

1.8

2.0

—

Primary gonarthrosis, bilateral

748

0.88

0.50

1.9

2.0

—

Car occupant injured in other and unspecified transport accidents

279

1.22

0.49

1.9

2.2

—

Chronic pancreatitis

171

1.29

0.49

1.7

2.1

—

Myocardial infarction, unclassifiable

250

0.78

0.49

1.6

1.9

—

Otosclerosis

101

1.39

0.49

1.8

—

Retinal detachment with retinal break

189

1.27

0.49

1.7

2.1

—

Other congenital malformations

180

1.28

0.49

3.4

2.0

—

Kela-code for severe mental illness

616

0.86

0.49

2.1

—

Insomnia

152

1209

0.92

0.49

2.2

2.0

—

Specific personality disorders

389

0.82

0.49

2.1

2.2

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

1.45

0.48

2.1

1.7

—

Tongue abnormality

1.45

0.48

1.2

2.0

—

Thiazolidinediones

166

0.72

0.47

1.8

2.0

—

Other and unspecified injuries of ankle and foot

1.49

0.47

2.7

2.3

—

Other diseases of gallbladder

1.49

0.47

4.6

1.7

—

Ptosis of eyelid

146

1.30

0.47

1.7

2.0

—

Use of antiglaucoma preparations and miotics

1.41

0.46

1.8

2.0

—

Melanocytic naevi of lower limb, including hip

1.46

0.46

3.0

1.9

—

Other diseases of peritoneum

1.46

0.46

1.6

1.8

—

Primary hyperparathyroidism

155

1.29

0.46

1.9

2.1

—

Benign neoplasm: Adrenal gland

111

1.35

0.46

4.0

2.1

—

Chondropathies

236

1.23

0.46

2.2

2.1

—

Benign neoplasm: salivary glands, exclude unknown (D119)

120

1.33

0.46

2.3

2.1

—

Other disorders of male genital organs

1.43

0.46

1.4

2.2

—

Nonorganic sleeping disorders, excluding more controls

282

1.21

0.46

3.1

2.1

—

Trigger finger

221

0.77

0.46

1.8

2.1

—

Other and/or unspecified nontoxic goitre

117

0.68

0.45

1.4

2.1

—

Impacted cerumen

118

0.68

0.45

2.5

2.2

—

Left bundle-branch block

1.43

0.45

2.9

2.0

—

Other complications of labour and delivery, not elsewhere classified

151

0.73

0.45

1.9

2.1

—

Glucagon-like peptide-1 (GLP-1) analogues

487

1.15

0.45

1.8

2.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

487

1.15

0.45

1.8

2.0

—

Migraine with aura

366

1.18

0.44

2.0

—

Other noninflammatory disorders of vagina

112

1.34

0.44

1.8

—

Neuralgia and neuritis, unspecified

1.45

0.44

2.5

2.1

—

Spirochaetal infections, other/unspecified

497

1.15

0.44

1.9

2.0

—

Status post-ami

285

0.83

0.44

1.7

2.0

—

Other peripheral vertigo

121

1.32

0.44

1.6

1.8

—

Gonarthrosis,primary

154

1029

0.92

0.44

1.9

2.0

—

Supervision of normal pregnancy

183

0.81

0.44

2.1

2.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.45

0.43

3.0

2.6

—

Scabies

211

1.23

0.43

1.7

2.2

—

Injuries to the neck

349

1.18

0.43

1.9

2.1

—

Assault by bodily force

104

1.35

0.43

2.1

2.0

—

Burns and corrosions confined to eye and internal organs

1.62

0.43

1.8

2.0

—

Spinal instabilities

1.62

0.43

1.0

1.7

—

therapeutic use

1.62

0.43

2.6

1.8

—

Hypertensive Renal Disease

1.61

0.43

1.6

2.7

—

Early onset COPD

340

1.18

0.43

1.5

2.0

—

Amputation

113

1.33

0.42

1.5

1.9

—

Transient global amnesia

122

1.31

0.42

2.1

1.9

—

Other congenital malformations of face and neck

1.56

0.42

1.0

2.3

—

Contact with other hot fluids

1.56

0.42

2.0

—

Bulimia nervosa (incl. atypical)

1.56

0.42

1.6

2.1

—

Coronary artery bypass grafting

277

0.83

0.42

2.3

2.0

—

Intracerebral haemorrhage

158

1.27

0.41

2.4

1.9

—

Carcinoma in situ of other and unspecified digestive organs

1.52

0.41

2.0

1.4

—

Disorder of external ear, unspecified

1.52

0.41

2.2

1.9

—

Benign neoplasm: Other and unspecified parts of mouth

1.52

0.41

1.4

2.1

—

Traumatic subarachnoid haemorrhage

1.52

0.41

2.0

2.5

—

Other bursitis of knee

0.00

0.41

0.0

1.5

—

Causalgia

0.00

0.41

0.0

1.5

—

Other chronic obstructive pulmonary disease, including avohilmo

742

1.10

0.41

1.5

2.0

—

Contusion of other and unspecified parts of foot

1.36

0.41

1.3

2.2

—

Central retinal artery occlusion

0.00

0.40

0.0

1.3

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.40

0.0

2.6

—

Dementia due to Parkinson's disease

0.00

0.40

0.0

1.6

—

Chronic conjunctivitis

1.47

0.40

2.2

—

Other specified disorders of external ear

1.47

0.40

1.4

2.0

—

Other benign neoplasm of uterus: Other parts/unspecified

1.47

0.40

1.6

1.4

—

Cluster headache, strict, including avohilmo

1.33

0.40

1.6

1.9

—

Retained placenta and membranes, without haemorrhage

168

1.25

0.40

1.6

2.0

—

Type 1 diabetes, wide definition, subgroup 1

333

1.17

0.40

2.0

2.3

—

Glucosamine medication

625

0.89

0.39

1.7

2.0

—

Fall on and from stairs and steps

411

0.85

0.39

1.7

2.1

—

Disorders of adult personality and behaviour

496

0.87

0.39

2.0

2.1

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.39

0.0

2.1

—

Anorexia (incl.atypical)

1.41

0.39

1.5

2.1

—

Nontoxic single thyroid nodule

106

1.32

0.39

4.2

1.9

—

Other intervertebral disc disorders

166

929

1.08

0.39

2.1

2.0

—

Wet age-related macular degeneration

190

1.23

0.39

2.0

1.8

—

Contraceptive management

519

0.89

0.38

2.3

2.1

—

Benign neoplasm: Cerebral meninges

124

1.29

0.38

1.7

1.8

—

Amiodarone users

124

1.29

0.38

1.4

2.0

—

Single spontaneous delivery

325

1.12

0.38

1.9

2.0

—

Foreign body or object entering through skin

1.38

0.38

2.2

2.0

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.39

0.38

4.0

2.2

—

Meralgia paraesthetica

1.39

0.38

1.6

1.8

—

Nontoxic goitre/thyroid nodule

438

1.14

0.38

2.3

2.0

—

Spontaneous abortion

524

1.11

0.38

1.8

2.0

—

Other obstetric trauma

1.34

0.38

2.2

—

Melanocytic naevi of other and unspecified parts of face

1.34

0.38

1.7

1.9

—

Hypertrophic disorders of skin

1.34

0.38

1.3

2.2

—

Dermatographic urticaria

1.35

0.38

1.8

2.1

—

Lesion of lateral popliteal nerve

1.31

0.37

2.1

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.35

0.37

2.4

1.5

—

Other other unspecified disorders of the circulatory system

1.35

0.37

2.0

1.8

—

Dislocation, sprain and strain of joint and ligaments of hip

1.35

0.37

1.6

1.8

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

107

1.31

0.37

3.2

2.1

—

Allergic urticaria

107

1.31

0.37

1.4

2.1

—

Postpartum haemorrhage due to retained placenta

170

1.24

0.37

1.8

2.2

—

Mental and behavioural disorders due to psychoactive substance use

104

1050

0.92

0.37

2.4

2.0

—

Lyme disease

496

1.13

0.37

1.9

2.0

—

Contact with machinery

152

1.25

0.37

2.5

2.1

—

Benign neoplasm of eye and adnexa

143

1.26

0.36

1.8

2.0

—

Gonarthrosis

120

629

1.09

0.36

1.9

2.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

202

0.85

0.36

1.9

—

Pain in thoracic spine

235

1.19

0.36

2.3

2.0

—

Distal bite

1.46

0.36

1.5

2.6

—

Allergic rhinitis

529

1.12

0.36

2.1

—

Later onset COPD

298

1.15

0.35

1.6

1.8

—

Endometriosis ASRM stages 1,2

263

1.18

0.35

1.5

2.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

1.43

0.35

3.5

2.3

—

Other/unspecified disorders of vestibular function

1.43

0.35

3.5

1.5

—

Hypertrophic cardiomyopathy

1.43

0.35

1.8

2.0

—

Other congenital malformations of skin

1.43

0.35

3.0

2.2

—

Residual foreign body in soft tissue

0.63

0.35

1.6

2.1

—

Endovascular or surgical operations to intracerebral aneurysms

0.63

0.35

1.6

—

Fall on and from ladder

1.31

0.35

3.8

1.9

—

Other and unspecified local infections of skin and subcutaneous tissue

135

1.26

0.35

1.9

2.2

—

LSIL lesion of the cervix uteri, vagina or vulva

208

1.20

0.35

2.6

2.1

—

Other specified and unspecified personality disorders

145

0.76

0.34

2.0

2.1

—

Cysts of oral region, not elsewhere classified

1.37

0.34

2.0

2.1

—

KRA_PSY_EATING, excluding more controls

1.31

0.34

1.6

2.3

—

Arthropathies in other diseases classified elsewhere

1.37

0.34

1.0

1.9

—

Helminthiases

1.36

0.34

1.8

2.3

—

Maternal care for other conditions predominantly related to pregnancy

313

0.85

0.34

1.8

2.1

—

Other hammer toe(s) (acquired)

201

1.19

0.34

2.0

—

Benign neoplasm of ovary

254

0.83

0.34

1.6

1.9

—

Other and unspecified injuries of wrist and hand

1.33

0.33

1.7

1.9

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

100

1.30

0.33

1.3

2.2

—

Benign mammary dysplasia

200

1.20

0.33

2.3

1.8

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

118

1.27

0.33

1.8

2.1

—

Mental disorders, not otherwise specified

118

1.27

0.33

2.1

—

Other diseases of oesophagus

118

1.27

0.33

2.1

2.3

—

Subarachnoid haemorrhage

144

0.76

0.33

1.5

1.9

—

Insulin, fast-acting (human)

210

0.81

0.33

2.0

2.3

—

Acute and transient psychotic disorders

188

0.80

0.33

1.9

2.0

—

Fracture at wrist and hand level

566

1.11

0.33

2.3

2.1

—

Atopic conjunctivitis

1.31

0.33

1.3

2.2

—

Artificial joint re-operation

0.70

0.33

1.7

1.5

—

COPD related to multimorbidity

519

1.11

0.32

1.5

2.0

—

Use of rivastigmine

154

0.78

0.32

3.5

1.7

—

Migraine with aura and triptan purchases

238

1.18

0.32

2.0

2.1

—

Other deformities of toe(s)

1.28

0.32

1.0

2.0

—

Delivery, wide proxy

271

0.88

0.32

1.8

2.0

—

Carpal tunnel syndrome

114

932

1.08

0.32

2.0

2.1

—

Cyst of kidney

1.31

0.31

1.9

2.0

—

Other (not insulin) diabetes medications

200

1121

1.06

0.31

1.9

2.0

—

Vasomotor rhinitis (mode)

101

1.29

0.31

1.3

2.0

—

Normotensive glaucoma

101

1.29

0.31

1.8

—

Fibroblastic disorders

348

0.86

0.31

1.7

2.0

—

Other specified/unspecified soft tissue disorders

1.32

0.30

3.6

2.0

—

Medical treatment for female infertility

303

1.15

0.30

1.9

2.1

—

Brachial plexus disorders

147

1.23

0.30

1.5

2.2

—

Thyrotoxicosis, other and/or unspecified

315

0.86

0.30

1.6

2.2

—

Anti-inflammatory and antirheumatic products, non-steroids

266

0.89

0.30

1.9

2.0

—

Suggestive for eosinophilic asthma

129

1.24

0.30

1.5

2.1

—

Bicipital tendinitis

1.34

0.30

1.3

2.3

—

Hernia of abdominal wall

792

1.09

0.30

2.3

2.0

—

Stroke, excluding SAH

110

746

1.08

0.30

2.1

1.9

—

Other and unspecified injuries of head

1.31

0.30

2.2

2.0

—

Injuries to the elbow and forearm

136

1121

1.07

0.29

2.3

2.0

—

Gonarthrosis, primary, with knee surgery

792

0.92

0.29

1.6

2.0

—

Pedal cyclist injured in noncollision transport accidents

174

0.80

0.29

3.4

2.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

1.25

0.29

1.0

2.4

—

Allergic contact dermatitis

194

1.19

0.29

1.8

2.0

—

Exposure to other specified factors

153

1323

1.06

0.29

1.8

2.0

—

Other benign neoplasms of connective and other soft tissue

148

1.22

0.29

2.1

—

Other diseases of arteries and capillaries

108

0.74

0.29

2.9

2.0

—

Foreign body in respiratory tract

1.23

0.29

1.6

2.1

—

Benign neoplasm: Colon, unspecified

392

1.12

0.28

2.3

2.0

—

Lumbar disc prolapse

124

890

1.07

0.28

2.0

—

Other blood glucose lowering drugs, excl. Insulins

238

0.84

0.28

1.8

2.1

—

Other disorders of the musculoskeletal system and connective tissue

227

0.84

0.28

1.6

2.0

—

Bipolar affective disorders

298

1.14

0.28

2.2

—

Polyhydramnios

1.29

0.28

2.5

2.6

—

Hydrocephalus

1.30

0.28

3.5

2.0

—

Maternal care for known or suspected fetal abnormality and damage

195

0.84

0.27

2.1

—

Cluster headache, wide,, including avohilmo

1.25

0.27

1.6

1.9

—

Substance abuse

103

1036

0.93

0.27

2.4

2.0

—

Sleep disorders

161

1228

0.95

0.27

2.2

2.0

—

Sequelae of other external causes

1.21

0.26

1.4

2.0

—

Unspecified mental disorder

698

0.92

0.26

2.0

2.1

—

L02BB Anti-androgens

104

1.25

0.26

1.4

2.1

—

Superficial injury of wrist and hand

300

1.13

0.26

1.9

2.1

—

Persons encountering health services for specific procedures, not carried out

1.26

0.26

2.2

2.6

—

Injury of unspecified body region

1.26

0.26

2.9

2.0

—

COPD, hospital admissions 1, only main diagnosis

436

1.10

0.26

1.4

1.9

—

Fracture of neck

0.68

0.26

2.0

2.1

—

Diabetic retinopathy

323

1.10

0.25

1.5

2.0

—

Other/unspecified enthesopathies, not elsewhere classified

123

1.22

0.25

1.1

2.1

—

Additional codes for the location of defect, injury or illness

1.22

0.25

4.0

1.9

—

Event of undetermined intent

1.20

0.25

3.2

2.1

—

Ischaemic Stroke, excluding all haemorrhages

100

696

1.07

0.24

2.4

1.9

—

Thyrotoxicosis with diffuse goitre

226

1.15

0.24

1.8

2.1

—

Other mental disorders due to brain damage and dysfunction and to physical disease

142

1.20

0.24

4.0

1.8

—

Achilles tendinitis

170

1.18

0.24

2.2

1.8

—

Injuries to unspecified part of trunk, limb or body region

133

1.20

0.24

2.6

2.1

—

Benign neoplasm: Choroid

1.28

0.24

1.8

2.0

—

Inflammatory disease of cervix uteri

0.72

0.24

2.2

1.9

—

Pedal cyclist injured in other and unspecified transport accidents

161

1.18

0.24

2.1

2.0

—

Aneurysms, operations, SAH

244

0.86

0.24

1.8

2.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

492

0.92

0.24

2.1

1.8

—

Ménière disease

124

1.21

0.24

1.4

1.8

—

Pregnancy, childbirth and the puerperium

227

0.90

0.23

1.8

1.9

—

Periapical abscess

784

1.07

0.23

1.9

2.1

—

Other fall from one level to another

341

1.11

0.23

2.4

2.1

—

Open wound of abdomen, lower back and pelvis

1.32

0.23

1.4

2.2

—

Mental and behavioural disorders due to cannabinoids

1.32

0.23

2.8

2.4

—

Open wound of hip and thigh

1.32

0.23

2.8

1.9

—

Benign neoplasm: Kidney

1.32

0.23

2.2

1.4

—

Other symptoms and signs involving general sensations and perceptions

1.32

0.23

1.4

1.9

—

Cerebral aneurysm, nonruptured

136

0.81

0.23

2.0

1.8

—

Diabetic maculopathy

170

1.16

0.23

2.0

1.9

—

Juvenile osteochondrosis

1.28

0.23

1.6

2.1

—

Other maternal disorders predominantly related to pregnancy

635

0.94

0.23

1.9

2.0

—

Suicide or other Intentional self-harm

390

1.10

0.22

2.2

2.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.77

0.22

2.7

2.1

—

Crushed, pushed or stepped on by crowd or human stampede

0.77

0.22

1.4

2.1

—

Bacterial meningitis

1.25

0.22

2.6

1.6

—

Injury of muscle and tendon at wrist and hand level

200

1.15

0.22

2.4

2.0

—

Foreign body on external eye

219

1.14

0.22

1.6

2.1

—

False labour

282

0.91

0.21

1.8

2.1

—

Pregnancy with abortive outcome

119

587

1.06

0.21

2.3

2.0

—

Other noninflammatory disorders of uterus, except cervix

234

0.89

0.21

2.6

2.0

—

Injury of nerves at shoulder and upper arm level

0.00

0.21

0.0

1.8

—

Contusion of toe(s) with damage to nail

0.00

0.21

0.0

2.0

—

0.00

0.21

0.0

1.6

—

Contracture of joint

0.00

0.21

0.0

1.4

—

Shoulder region

0.00

0.21

0.0

2.8

—

Hydatidiform mole

0.00

0.21

0.0

2.2

—

Thyroiditis, unspecified

0.00

0.21

0.0

2.3

—

Circumscribed brain atrophy

0.00

0.21

0.0

1.5

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.21

0.0

1.6

—

1.19

0.21

3.6

1.8

—

Persons encountering health services in circumstances related to reproduction

104

742

0.94

0.21

2.0

2.1

—

Personality disorders

461

0.91

0.21

2.0

2.1

—

Previous suicide attempt

0.00

0.21

0.0

1.9

—

Intentional self-harm by unspecified means

0.00

0.21

0.0

2.0

—

Diabetic nephropathy

217

0.86

0.21

1.6

1.9

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

0.21

0.0

4.1

—

Congenital malformations and deformations of the musculoskeletal system

153

1.17

0.21

2.2

—

Other congenital malformations of skin

101

0.79

0.21

4.4

2.1

—

Sequelae of cerebrovascular disease

469

0.92

0.21

2.5

1.8

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

105

0.76

0.21

3.0

2.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

172

1273

0.96

0.21

2.2

2.0

—

Other degenerative diseases of the basal ganglia

0.00

0.21

0.0

1.3

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.21

0.0

2.4

—

Poisoning by medicine, drug-induced

0.00

0.20

0.0

2.4

—

UC patients in KELA-register (code 208), prior to 1994

1.25

0.20

1.2

1.9

—

Early complications of trauma

1.25

0.20

1.7

2.1

—

!Aliquae complicationes praecoces traumatis

1.25

0.20

1.7

2.1

—

Obstructed labour due to maternal pelvic abnormality

208

0.87

0.20

1.8

2.0

—

Injuries to the ankle and foot

140

1188

1.05

0.19

1.9

2.0

—

Superficial injury of head

355

1.10

0.19

2.4

2.1

—

Complications of the puerperium, not elsewhere classified

1.20

0.19

2.0

2.4

—

Personality disorders, excluding more controls

384

1.09

0.19

2.0

2.1

—

Atrophic disorders of skin

212

1.13

0.19

1.8

1.9

—

Monoamine oxidase A inhibitors

165

1.15

0.19

2.6

2.0

—

Benign neoplasm of other and unspecified female genital organs

1.15

0.19

1.8

1.9

—

Female genital prolapse

271

0.92

0.19

2.0

—

Persistent mood disorders

289

1.11

0.19

2.1

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.13

0.18

2.2

2.1

—

Stroke, including SAH

117

808

1.05

0.18

2.1

2.0

—

Peripheral artery operations in Hilmo

156

1.15

0.18

1.5

1.9

—

Type 1 diabetes, wide definition

357

1.09

0.18

2.0

2.3

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1.17

0.17

1.0

2.4

—

Other and unspecified mood [affective] disorders

1.21

0.17

2.5

2.1

—

Generalized anxiety disorder

233

1.12

0.17

2.3

2.1

—

Benign neoplasm: Rectum

281

1.10

0.17

1.6

2.1

—

Panic disorder

214

1.12

0.17

1.6

2.1

—

Adenomyosis (Endometriosis of uterus)

205

0.88

0.17

1.8

2.2

—

Preterm labour and delivery

368

1.09

0.17

2.6

2.0

—

Struck by thrown, projected or falling objec

1.11

0.17

2.3

2.0

—

Need for other prophylactic measures

0.71

0.16

3.2

2.4

—

Effects of foreign body entering through natural orifice

388

1.08

0.16

1.6

2.1

—

Lesion of ulnar nerve

215

0.88

0.16

1.6

2.0

—

Labour and delivery complicated by umbilical cord complications

1.16

0.16

1.5

2.1

—

Special screening examination for neoplasms

1.16

0.16

1.6

2.1

—

Inguinal hernia

115

735

1.05

0.16

2.1

2.0

—

Maternal care for known or suspected malpresentation of fetus

201

0.90

0.16

2.2

—

Fenamates

167

0.89

0.16

1.7

2.0

—

Other obstructed labour

111

1.17

0.15

1.9

2.0

—

Benign neoplasm: Transverse colon

149

1.14

0.15

2.1

1.9

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD8 cells/100 lymphocytes in Specimen

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS